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3ABSTRACT
Deficiencies in DNA mismatch repair have been found in hereditary cancers as 
well as in sporadic cancers, illustrating the importance of mismatch repair in maintaining 
genomic integrity. To determine if inefficient mismatch repair can contribute to hotspots 
o f mutation, repair rates were determined in vivo in mammalian cells for mismatched 
nucleotides located at H-ras codon 10 and compared to previously determined repair 
rates at a nearby activating hotspot of mutation, H-rav codon 12. Repair rates for H -ras 
codon 10 are significantly improved over repair rates at codon 12. This indicates that 
inefficiencies in mismatch repair are responsible, at least in part, for the well-documented 
hotspot o f mutation at codon 12 and that surrounding sequence context can effect repair 
o f mismatches. Gel-shift analysis demonstrates that the degree of binding by the initial 
mismatch recognition factor hM utSa (heterodimer of hMSH6 and hMSH2) correlates 
with in vivo repair rates for each mismatch tested at the codon 12 location. UV cross- 
linking of nuclear proteins to G:A and G:T mismatches at codon 10 or codon 12 
generally confirm these results. Overall this suggests that there is lowered efficiency in 
the kinetics of mismatch repair at codon 12, perhaps in the initiation step, rather than 
inaccurate repair leading to mutation.
The interactions of specific mismatch repair proteins in human nuclear extracts 
were then examined to determine the proteins binding to mismatched DNA. 
Immunoprecipitation followed by Western blotting indicates two novel complexes that 
exist in the absence of ATP: one consisting of hMSH2, hMSH6, hMLHl and hPMS2 
and the other consisting of hMSH2, hMSH6, hMLHl and hPM Sl. Furthermore, the
4protein complexes specifically bind to mismatched DNA and not to a similar homoduplex 
oligonucleotide. The protein complex-DNA interactions occur primarily through 
hMSH6, although hMSH2 can also become cross-linked to the mismatched substrate. In 
the presence of ATP, the binding of hMSH6 to mismatched DNA is decreased. In 
addition, hM LHl, hPMS2 and hPMSl no longer interact with each other or with the 
hM utSa complex. However, the ability of hMLHl to co-immunoprecipitate mismatched 
DNA increases in the presence of ATP, suggesting a role for hMLHl in subsequent 
ATP-dependent repair processes.
5page
Signature Page 1
Title Page 2
Abstract 3
Table of Contents 5
List o f Figures 8
List o f Tables 9
I. Introduction 10
A. DNA Damage, Mutations and Cancer 10
B. DNA Repair 12
1. Damage reversal 12
2. Base excision repair 13
3. Nucleotide excision repair 17
4. Mismatch repair 22
a. Mismatch repair in E. coli 22
b. Human MutS homologs 25
c. Human MutL homologs 31
d. Interactions between the MutS and MutL homologs 33
e. Other proteins involved in eukaryotic mismatch 34
repair
f. Strand discrimination 35
g. Other functions of the mismatch repair proteins 37
TABLE OF CONTENTS
6C. Hotspots of Mutation and Mismatch Repair 40
II. Materials and Methods 45
A. Enzymes, Antibodies and Reagents 45
B. Plasmid and M l3 Constructs 46
C. Heteroduplex Preparation for Mismatch Repair Analysis 47
D. Cell Lines and Transfection 52
E. Mismatch Repair Analysis 53
F. Preparation of Oligonucleotides for Gel-Shift Assays 56
G. Gel-Shift Assays 58
H. Preparation of Oligonucleotides for UV Cross-linking,
Immunoprecipitation and Western Blotting Assays 59
I. UV Cross-linking and Immunoprecipitation 60
J. Western Blotting 62
K. Molecular Weight Determination 64
III. Results 65
A. In Vivo Mismatch Repair Rates 65
B. In Vitro Nuclear Protein Binding to Mismatches at the Codon 12 
Hotspot and at Codon 10 70
C. In Vitro Mismatch Repair Protein Interactions 75
1. hMSH6, hMSH2, hM LHl, and either hPMS2 or hPMSl 
form a mismatch repair protein complex that interacts 
specifically with heteroduplex DNA 75
2. Protein interactions after addition of ATP 87
73. Comparison of mismatch repair protein interactions with
G:A and G:T mismatches at codons 10 and 12 91
IV. Discussion 95
V. References 113
1. Human Base Excision Repair
2. Human Nucleotide Excision Repair
3. E. coli MutS/L/H Mismatch Repair
4. Mismatch Plasmid Construction
5. Example of Agarose Gels from Mismatch Repair Analyses
6. Comparison of Mismatch Repair Rates for H-ras Codon 10 and Codon 12
7. Relative Amounts of Nuclear Protein Binding to Specific Mismatches at 
Codon 10 or Codon 12 of Yi-ras
8. Effect of Anti-hMSH6 Antibody and ATP on Mismatch Specific Binding
9. Competition Assays
10. hMSH6 Immunoprecipitation and Subsequent Autoradiogram and 
Western Blots
11. hMLHl Immunoprecipitation and Subsequent Western Blotting
12. hMSH2 Immunoprecipitation and Subsequent Western Blotting
13. hPMSl and hPMS2 do not Co-immunoprecipitate Each Other
14. hMSH2 and hMLHl Immunoprecipitation in the Absence o f 32-mer 
oligonucleotide DNA
15. UV Cross-linking and Immunoprecipitation of Protein-DNA Complexes
16. UV Cross-linking and Immunoprecipitation in the Absence or Presence 
o f ATP
17. DNA-Protein UV Cross-linking and Subsequent Immunoprecipitation to 
G:T and G:A Mismatches at Codon 10 or Codon 12
18. Proposed Mismatch Repair Protein Interactions
LIST OF FIGURES
15
20
23
49
55
66
71
73
74
77
80
81
82
84
85
88
92
101
page
LIST OF TABLES
1. Relationships between MutS and MutL homologs
2. Repair of mismatches at codon 10 of H-ras in E. coli.
3. Repair of mismatches at codon 10 of H-ras in non-synchronized
10
I. Introduction
A. DNA Damage, Mutations and Cancer
Faithful maintenance of the genome is crucial for an individual’s health and for 
propagation o f the species. Unfortunately, DNA is constantly under attack, both from 
within and without, with the large genomes of mammalian cells making them especially 
vulnerable (for review of DNA damage see 1, 2). There are a number of sources of 
potential damage, one of which is mis-copying by the DNA replication enzymes (3). 
Although the main mammalian replicative polymerase, DNA polymerase 8, includes its 
own 3 ’ ->  5 ’ exonucleolytic proofreading capability, occasionally deletions, insertions 
and misincorporated nucleotides occur. As well, the DNA molecule itself exhibits some 
intrinsic instability, with tautomeric shifts, deaminations and 
depurinations/depyrimidinations constantly occurring. Perhaps most insidiously, 
necessary endogenous reactions such as those of aerobic respiration, produce reactive 
oxygen species and free radicals which can damage DNA through oxidative chain 
reactions. These reactions produce strand breaks, base loss and potentially mispairing 
residues such as thymine glycol and 8-hydroxyguanine. Finally, exogenous agents such 
as UV light, benzopyrene, aflatoxin, and cisplatin can attack DNA, both directly and 
indirectly, causing helix-distorting DNA lesions.
These damaging events take their toll on DNA. Overall, a single mammalian 
DNA molecule is estimated to undergo approximately 100,000 modifications per day (4).
However, in spite of this constant assault, the spontaneous mutation rate in normal cells is 
low (approximately 2 x 10'7 mutations/gene/cell division) (1,5). Obviously, efficient 
cellular mechanisms exist to repair most DNA damage. Sometimes though, mutations do 
occur despite the cell’s best efforts. If they accumulate in several specific oncogenes 
and/or tumor suppressor genes a cell can acquire a transformed phenotype. Considering 
the rate of mutation, this has been calculated to be extremely unlikely to occur, leading to 
the hypothesis that an early event in tumorigenesis may be a gene mutation conferring a 
mutator phenotype (genome-wide elevation in mutation) (6). Evidence for the resulting 
genomic instability has recently been discovered in studies o f sporadic tumors where 12- 
15% were found to contain thousands of mutations in microsattelite sequences (7).
Even more compelling evidence for the mutator theory comes from studies of 
‘cancer families’, for example hereditary non-polyposis colon cancer (HNPCC) kindreds 
(for reviews see 8 - 11). HNPCC is an autosomal dominant disease in which family 
members are pre-disposed to early-onset colon cancer as well as tumors in the ovary, 
endometrium, stomach, pancreas, small intestine, skin and urinary tract. In these families 
germ-line mutations have been found in the genes associated with a specific DNA repair 
mechanism; long-patch mismatch repair. The individual’s DNA contains a germline 
defect in one allele, while in tumor cells the remaining wild-type allele is typically lost or 
mutant (12). The result is a measurable elevation o f the genome-wide mutation rate in 
the tumor cells (13), leading to the accumulation of mutations in genes that provide the 
selective advantages needed for a cell to give rise to a tumor. Further analysis has 
revealed that many spontaneous tumors that display increased mutation rates and
microsattelite instability also contain mutations in one of the long-patch mismatch repair 
genes (14, 15). This exciting research has forged a direct link between mutations in DNA 
repair genes, elevated mutation rate, and a predisposition to cancer, and has led to an 
increased interest in the mechanisms of mismatch repair. It is hoped that future 
developments in the field o f DNA repair will lead to better diagnosis, treatment and 
perhaps, eventually, prevention of cancer.
B. DNA Repair
I. Damage reversal
O f the DNA repair mechanisms the simplest is direct damage reversal, for 
example ligation of strand breaks by DNA ligase (1). Another direct damage reversal 
system functions to photoreactivate UV damage. Although this system is extremely 
common it does not appear to occur in mammalian cells, perhaps reflecting our evolution 
from hair-covered nocturnal ancestors. Placental mammals can, however, directly 
reverse damaged 0 6-methylguanine residues and to a lesser extent 0 4-alkylthymine 
residues (for review see 1, 16). These are generated endogenously due to reactive 
cellular catabolites that act as monofunctional alkylating agents (17). 0 6-methylguanine 
residues are highly mutagenic as they can pair with approximately equal ability to both C 
and T nucleotides, causing transition mutations. These mispairs attract the attention of 
the long-patch mismatch repair system (see below), which attempts repeatedly to repair
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the mispair leading to a futile cycling that can result in cell death. To prevent this from 
occurring, alklytransferase enzymes remove deleterious methyl and larger alkyl groups 
from damaged nucleotides by transferring them covalently to one o f their own cysteine 
residues (18). Interestingly, the alkyltransferase enzymes, which are also called “suicide 
enzymes”, are themselves consumed in this process. As the entire protein molecule is 
sacrificed for each lesion corrected, this mode of repair is obviously only suitable for 
removing rare but highly mutagenic DNA lesions. The energetic expense involved in 
such a system demonstrates the cellular importance of DNA repair mechanisms. It is also 
interesting to note that the gene for the alkyltransferase enzyme is one o f the few DNA 
repair genes that can be transcriptionally activated by treatment with a DNA damaging 
agent, in this case by alkylating agents, UV light or X-rays (1, 19). This induction 
appears to be limited to liver cell lines (19 -21 ), presumably reflecting the increased 
exposure that can occur in this organ.
2. Base excision repair
The base excision repair pathway removes common DNA modifications, such as 
those caused by endogenous agents. It is thought to be, quantitatively at least, the most 
active repair system and is characterized by a small repair tract ( 1 - 6  nucleotides) and by 
restricted repair specificities (for review see 1, 22, 23). The initiating enzyme in standard 
base excision repair is a DNA glycosylase. Eight human DNA glycosylases have now 
been identified (22), many of which have Escherichia coli homologs. Two of these can
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function to repair the mismatched nucleotides examined in these studies. Specifically, in 
HeLa cell extracts a thymine DNA glycosylase specialized for G:T mismatches has been 
identified which removes thymine in G:T mispairs to form G:C (24). hMYH, the 
mammalian homolog of E. coli mut Y, has also been identified. This removes adenine 
from A:G mismatches and A:8OH-G (25). In each case the glycosylase moves by 
facilitated diffusion along the minor groove o f DNA until it recognizes its specific type of 
damaged nucleotide. The glycosylase enzymes are believed to then kink the DNA by 
compression of the strand and to “flip” out the abnormal residue into a recognition pocket 
(26). Cleavage of the N-glycosidic bond between the base and the deoxyribose occurs 
leaving behind an apurinic or apyrimidinic (AP) site (see Figure 1) (27 - 29). The DNA 
strand is cleaved by the glycosylase 3 ’ to the AP site if the glycosylase is bifunctional 
(30, 31). If the glycosylase is monofunctional it complexes with a separate AP 
endonuclease (APE 1/HAP 1) which cleaves the DNA 5’ to the AP site (32). From this 
point the repair process can occur via two pathways. In short-patch base excision repair 
(one nucleotide repair patch) DNA polymerase (3 joins the base excision repair complex 
and the remaining deoxyribosephosphate residue (dRP) is completely excised by a 
phosphodiesterase activity (dRP lyase) o f DNA polymerase (3 (32). The one nucleotide 
gap is filled in by DNA polymerase P using the intact complementary strand and the nick 
is sealed by DNA ligase III complexed together with XRCC1 (33). XRCC1 has been 
shown to interact with DNA polymerase (3, and presumably acts as an adaptor molecule, 
bringing DNA ligase III to the site of repair (33, 34). The other base excision pathway is 
the so called long-patch base excision repair (2 - 6 nucleotide repair patch). In this
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Figure 1 -  Human Base Excision Repair. See text for description o f the processes. 
Figure is adapted from Krokan et. al., 1997 (22).
process DNA polymerase 5 or 8 replicates a short repair patch in the presence of PCNA 
(Proliferating Cell Nuclear Antigen) and RFC (Replication Factor C) (35 - 37). DNAase 
IV (FEN1) acts to excise the resulting overhang containing the dRP residue (38). DNA 
ligase I is then believed to complete the repair process by sealing the final nick (22). 
Interestingly, recent evidence has shown that base excision repair occurs more efficiently 
on transcribed DNA and that this may be of critical importance in repair of oxidative 
lesions (39, 40). This type o f interaction suggests a potential physical correspondence 
between the DNA glycosylases and the transcription machinery.
One consideration in base excision repair is the use of DNA polymerase (3, which 
unlike DNA polymerase 5 or s, does not have a 3’ ->  5’ exonuclease activity, and as such 
shows a relatively high error frequency (1 in every 3000 to 5000 nucleotides) (3, 41, 42). 
Two mechanisms are currently known to serve to protect against such replication errors. 
First, DNA ligase III has been shown to be relatively inefficient at joining nicks with a 3’ 
mismatched residue, leaving time for excision of the mismatched nucleotide (43). 
Secondly, a new mammalian 3 ’ exonuclease has been found that is believed to function 
in editing of DNA polymerase (3 replication (44, 45). Together, these mechanisms could 
serve to produce the high degree of repair fidelity necessary for mutation avoidance.
Apurinic/apyrimidinic sites that occur due to spontaneous hydrolysis are also 
repaired by the base excision repair system with the AP endonuclease (APE 1 /HAP 1) 
recognizing and initiating repair (46, 47). Abasic sites generated in this way may indeed 
outnumber those produced by DNA glycosylases as knockout mice for the various DNA 
glycosylases so far investigated are viable, whereas knockouts for APE/HAP 1 are not
16
(48). Although base excision repair pathways are believed to be primarily responsible for 
repair of the most commonly damaged nucleotides, as yet no direct link has been found 
between loss of base excision repair and increased cancer incidence.
3. Nucleotide excision repair
The nucleotide excision repair system acts to repair helix-distorting DNA lesions 
and is characterized by a 24-32 nucleotide repair tract (for reviews see 1,16, 49). It 
responds to a large range of damage that produces local distortions in the DNA, including 
the bulky chemical adducts, alkylating chemical adducts and cross-links that are caused 
by exogenous DNA damaging agents, ionizing radiation and endogenous reactions. Also, 
nucleotide excision repair in humans removes the pyrimidine dimers caused by UV light, 
which may indeed be its most important function (see below).
Reduced levels of nucleotide excision repair is associated with three recessive 
genetic disorders in humans: Cockayne’s syndrome (CS), trichothiodystrophy (TTD) and 
xeroderma pigmentosum (XP) (50). In Cockayne’s syndrome patients exhibit growth 
retardation, neurological deficiencies, skeletal abnormalities and shortened lifespan. 
Trichothiodystrophy patients have brittle hair, short stature, scaly skin, mental 
underdevelopment and shortened lifespan. Of these disorders only XP is associated with 
an increased incidence of cancer, perhaps due to the relatively normal lifespan of these 
individuals. XP patients display a 2000-fold increased risk o f skin cancer and an 
approximately 10-fold increased risk of common internal cancers (16). This incremental
17
risk of internal cancers compared to the much higher incidence of skin cancers reflects 
the importance of nucleotide excision repair in removal of the pyrimidine dimers caused 
by UV radiation. XP is a rare but heterogenous disease in which seven genetic 
complementation groups have been identified (XPA ->  XPG). Study of the protein 
products of these genes has shed considerable light on the basic pathways in nucleotide 
excision repair.
The general mechanisms of human nucleotide excision repair appear to be 
biochemically similar to those in the E. coli UvrABC pathway (for review see 16, 51), 
demonstrating through evolutionary conservation the importance of DNA repair 
mechanisms. Essentially, nucleotide excision repair involves dual incision by ATP- 
dependent nucleases followed by excision of the oligomer and filling in and ligation of 
the resulting gap. However, the eukaryotic pathway involves a far greater number of 
protein products, many of which do not show homology to the E. coli proteins (52 - 54). 
In humans, six core factors comprising 15-18 polypeptides appear to be involved in the 
dual incision. An additional 10-14 polypeptides are then necessary for the repair 
synthesis. It appears that in eukaryotes the basic pathways have been evolutionarily 
expanded upon with proteins involved in other cellular mechanisms taking on roles in 
nucleotide excision repair. In fact, many of the proteins involved in nucleotide excision 
repair have essential functions in other disparate cellular events. For example, RPA 
(Replication Protein A) functions in replication and recombination as well as in 
nucleotide excision repair (47). The ERCC1-XPF heterodimer functions in repair of
double-stranded breaks (55) and the XPG gene promotes the activity of the hNth DNA 
glycosylase in base excision repair (39, 40).
The first step in global genome nucleotide excision repair appears to be 
recognition o f a helix distortion by the XPC-hHR23B complex in an energy-independent 
manner (see Figure 2) (56). Although this is somewhat controversial (57), XPC- 
hHR23B has the greatest affinity among the nucleotide excision repair enzymes for 
damaged nucleotides (56) and it is not required in transcription-coupled repair where a 
separate damage recognition activity is believed to exist (see below). A multi-protein 
repair complex then forms involving XPC-hHR23B, XPA (possibly involved in damage 
verification), the single-stranded binding heterodimer RPA (also possibly involved in 
damage verification), the XPG nuclease, the heterodimeric ERCC1-XPF nuclease, and 
the TFIIH complex, which includes the XPB and XPD proteins (58 - 60). A key 
intermediate in nucleotide excision then forms with the DNA unwinding to form an open 
“bubble” structure surrounding the lesion. This process uses the ATP-dependent helicase 
activities of the XPB and XPD proteins (both part of the TFIIH complex). Mutations in 
XPD are also the causative factor in TTD patients (61). Formation of the open bubble 
structure creates sites for excision by the XPG and ERCC1-XPF nucleases (62, 63).
These recognize junctions between single-stranded and double-stranded DNA with 
different polarities (XPG ->  3’, ERCC1-XPF ->  5’). A 24 to 32 residue oligonucleotide 
is thus released. The resulting gap is then filled in by the DNA polymerase 5 or £ 
holoenzymes in an RPA, RFC and PCNA-dependent manner, and the nicks are sealed, 
presumably by DNA ligase 1 (64, 65).
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Figure 2 -  Human Nucleotide Excision Repair. See text for description of processes. 
Figure is adapted from Lindahl and Wood (47).
The one XP complementation group not discussed so far is XPE. These cells 
harbor mutations in the UV-DNA damage binding factor E (UV-DDE) and although XPE 
cells are moderately UV sensitive, the function of this gene is not clearly understood (66 - 
69). It has been suggested that it may have a specialized function in detection and/or 
repair of DNA damage in chromatin where specialized nucleotide excision repair systems 
may exist (70).
This general model for nucleotide excision repair represents the reactions as they 
are believed to occur on non-transcribed DNA, which is indeed the bulk of the genome. 
Interestingly, a distinctive type of nucleotide excision repair has been demonstrated to 
occur on transcribed DNA, with transcribed genes being repaired faster than 
complementary non-transcribed sequences and the template strand of transcribed genes 
being repaired faster than the complementary non-template strand (71 - 74). Nucleotide 
excision repair that is modulated by transcription is now called transcription-coupled 
repair and has been shown to function similarly to the process described above, but 
without the need for the XPC-hHR23B gene products (75 - 77). While XPC-hHR23B is 
required in global genome repair, probably for recognition o f the initial helix distortion 
and recruitment of the nucleotide excision repair complex, RNA polymerase II arrest at a 
lesion is believed to serve this role in transcription-coupled repair (78). RNA polymerase 
II is then thought to recruit the other necessary nucleotide excision repair factors as well 
as recruiting the CS-A and CS-B proteins (71, 78, 79). Mutations in these proteins are 
the causative agents in Cockayne’s syndrome and are thought to couple RNA polymerase 
II arrest to repair. The nucleotide excision proteins, both those involved in global
21
genome and transcription-coupled repair are critical in maintaining genomic integrity and 
normal metabolism as graphically illustrated by the severity of the human diseases 
associated with their mutation.
4. Mismatch repair
a. Mismatch repair in E. coli
Long-patch mismatch repair (hereafter referred to as mismatch repair) is a broad 
specificity mispair correction mechanism believed to be responsible for repair of most 
mismatches generated during replication and recombination (for reviews see 80 - 82). 
Although the precise functions of the human mismatch repair proteins are just beginning 
to be understood, they are homologous to those in the relatively well-characterized E. 
coli MutSLH strand-specific mismatch repair pathway (for review see 83). Indeed, the 
degree of conservation between such divergent species reflects the essential role of 
mismatch repair. In bacteria, the proteins involved in mismatch repair have been isolated 
to near homogeneity and the entire system has been reconstituted in vitro (84). The first 
step in the repair process is recognition of and binding to a mismatch by a homodimer or 
tetramer of the 95 kDa MutS protein, which initiates the repair process (see Figure 3) (85 
- 87). Next, the DNA-bound MutS interacts with a homodimer o f the 68 kDa MutL 
protein to form a complex in a reaction that depends on ATP binding, but not on ATP 
hydrolysis (88 - 90). This complex translocates along the DNA strand, forming an 
a -loop  structure with the proteins resting at the crossover point (91). This process
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Figure 3 -  E. coli MutS/L/H Mismatch Repair. See text for description of the 
processes. Figure is adapted from Modrich and Lahue, 1996 (80).
requires ATP hydrolysis by MutS and although the exact role MutL plays is unclear, it 
does enhance MutS binding (92) and increase the rate o f loop growth (91). The 
MutS/Mut L complex is then believed to associate with the 25 kDa MutH protein, 
although the exact chronological order of association events has not been conclusively 
demonstrated. Assembly activates a latent endonuclease activity of MutH, which incises 
the unmethylated DNA strand at the nearest d(GATC) site either 3’ or 5’ to the mismatch 
(the process is bi-directional) (93 - 96). MutL helps to load DNA helicase II 
(MutU/UvrD) onto the site and the helicase is activated in a MutS/MutL/mismatch- 
dependent manner (96 - 98). A segment of DNA is then unwound by the helicase (99) 
and excised by Exo I (when the nick is 3 ’ to the mismatch), or RecJ/Exo VII (when the 
nick is 5’ to the mismatch) (100, 101). The resulting single-stranded tract extends from 
the strand break to several discrete sites 100 to 150 nucleotides beyond the mismatch and 
is stabilized by single-stranded binding protein (SSB) (87). The segment of DNA is 
finally re-synthesized by the DNA polymerase III holoenzyme and the remaining nick is 
sealed by DNA ligase (84).
Although this working model of E. coli mismatch repair is generally agreed upon, 
a few mysteries remain. One of the most important o f these concerns the unknown 
biochemical function of MutL. One suggestion is that MutL serves as a “molecular 
matchmaker”, facilitating the interaction between MutS and MutH (83, 92). Evidence for 
this comes from studies utilizing electron microscopy where a ternary complex of MutS, 
MutL and MutH was observed on the a-loop structure (91). Two-hybrid studies 
identified the interaction between MutL and MutH and protein affinity chromatography
experiments confirmed that MutL, and not MutS, physically associates with MutH (96). 
Furthermore, MutL can stimulate the endonuclease activity o f MutH in the absence of 
MutS and a mispaired base (96). MutL has also been suggested to play a role in loading 
the helicase onto the nicked strand (98, 99). Another suggestion for a biochemical 
function for MutL arises from MutL’s observed homology to class II DNA 
topoisomerases and the molecular chaperone molecule Hsp90 (102). Similar to Hsp90, 
MutL binds ATP and has a weak ATPase activity that is stimulated by ATP (103, 104). 
This suggests that MutL may also act as a molecular chaperone, perhaps facilitating the 
conformational changes necessary for the mismatch repair proteins to function.
b. Human MutS homologs
In humans, the mismatch repair pathway is homologous to but more complex than 
that o f£ . coli. For example, six MutS homologs (MSH1-MSH6) have now been 
demonstrated to be involved in eukaryotic mismatch repair (see Table 1) (for review see 
105). All of these display a high degree of homology in the C-terminus helix-tum-helix 
domain that is involved in protein-protein interactions (106) and are nearly invariant in 
the Walker Type A nucleotide binding domain (107). As in E. coli, the MutS homologs 
appear to function in the initial recognition step of mismatch repair, but unlike E. coli 
where they act as homodimers, in eukaryotes they function as heterodimeric complexes, 
(108, 109). Thus, there is an inherent asymmetry in the eukaryotic mismatch repair 
system that is presumed to be reflected in protein function.
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Table 1 - Relationships between MutS and MutL homologs.
E.coli protein 5. cerevisiae protein Human protein Size o f  human 
protein (kDa)
HNPCC kindreds
MutS MSH1 Not reported N/A N/A
MSH2 hMSH2 102 ~ 36 %
MSH3 hMSH3
(DUG1, MRP1)
127 None known
MSH4 hMSH4 Not reported None known
MSH5 hMSH5 93 None known
MSH6 MSH6
(GTBP)
160 2 known families
MutL MLH1 MLH1 70 ~ 60 %
MLH2 PMS1 115 1 known family
MLH3 Not reported N/A N/A
PMS1 PMS2 116 2 known families
O f the MutS homologs, hMSH2 was the first gene to be associated with the 
HNPCC cancer syndrome, with approximately 36% of kindreds now known to carry 
mutations in this gene (8, 11, 110, 111). It encodes a protein o f 102 kDa and like its E. 
coli homolog, purified hMSH2 homodimers have been shown to bind specifically in vitro 
to DNA substrates containing mismatches or small insertion-deletion loops, although the 
possible function and/or relevance of an hMSH2 homodimer is unknown (106, 112, 113). 
Tumor cell lines deficient in hMSH2 have been found to display high rates of mutation
(114- 116), and, extracts from these cells have been shown to be deficient in repair of 
mismatches and small insertion-deletion loops of 1 to 5 bases (108, 116).
Mismatch repair in hMSH2 deficient cell lines can be restored by a protein 
activity that was found to contain both hMSH2 and the 160 kDa hMSH6 protein (also 
known as GTBP), in a complex that is referred to as the hMutSa heterodimer (108, 117). 
Interestingly, hMSH6 had been isolated previously based on its ability to bind 
preferentially to G:T mispairs (hence GTBP for G:T binding protein) (118). It was 
subsequently demonstrated that the binding activity that was believed to be the 160 kDa 
hMSH6 protein and a 100 kDa breakdown product of hMSH6 was actually the hMutSa 
heterodimer of hMSH6 and hMSH2 (117). Further work with purified proteins has 
demonstrated that hMSH6 does not bind heteroduplex DNA on its own, but must be 
complexed with hMSH2 (117, 119).
Much current analysis has focused on the biochemical function of hMutSa. As 
stated previously, the most highly conserved area of both hMSH2 and hMSH6 is the 
Walker Type A nucleotide binding fold. Both hMSH2 and hMSH6 have been shown to 
possess intrinsic ATPase activity (118, 120, 121) and this ATPase activity has been 
shown to be required for function (120 - 122). Mutations in the consensus site for 
nucleotide binding of either hMSH2 or hMSH6 results in decreased ATPase activity and 
a decreased capacity to promote mismatch repair in vitro (120, 122). The ATPase 
activity is stimulated by DNA and has been shown in some cases to be stimulated more 
efficiently by DNA containing mismatched bases (119, 121, 123, 124). Thus it can be
concluded that the ATPase activity of hM utSa is central to its biochemical function in 
mismatch repair.
The hM utSa heterodimer binds specifically to heteroduplex DNA in vitro in the 
absence of additional ATP (108, 117, 119) with the Kd for hM utSa binding to 
homoduplex DNA estimated to be approximately 20-fold lower than for heteroduplex 
DNA (120). Due to the asymmetry of the heterodimers, it is reasonable to assume that 
each subunit will play a specific role in the repair process. It appears that the interaction 
with the DNA occurs via hMSH6, as it alone is capable of becoming UV cross-linked to 
oligonucleotide substrates (120). Conversely, ATP has been found to become cross- 
linked with increased efficiency to hMSH2 as compared to hMSH6 (120), and studies 
using mutants have shown that disruption of the ATPase activity of hMSH2 has a greater 
effect on in vitro repair than do ATPase mutants of hMSH6 (121, 122). Therefore, 
hMSH2 appears to play the predominant role in ATP binding and hydrolysis.
Numerous studies have demonstrated that the hM utSa heterodimer releases from 
oligonucleotide substrates upon addition of ATP (108, 119 - 121). This reaction has been 
shown to be dependent upon ATP binding but not on ATP hydrolysis, as it can be 
facilitated by non-hydrolyzable analogs o f ATP and by mutants deficient in ATP 
hydrolysis but not ATP binding (120, 121, 125). Based on these reports it has been 
postulated that hM utSa acts as a molecular switch, analogous to G-proteins such as Ras 
(121). In this model the hMSH2-hMSH6 molecular switch is ‘on’ (bound to a mismatch) 
in the ADP-bound form and ‘o ff in the ATP-bound form. In a more refined version of 
this model the ‘o ff  form has recently been described as a sliding clamp whereby the
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hMutSa heterodimer dissociates from the mismatch but remains bound to the DNA 
(126). Hydrolysis of the ATP molecule results in the recovery o f the mismatch binding 
capability whereas ADP-ATP exchange results in dissociation away from the mismatch. 
Exchange of ADP ->  ATP is provoked by mismatch recognition and/or binding, and thus 
regulates the hM utSa molecular switch.
A second model has also been proposed to describe the action of ATP on 
hMutSa. In the translocation model, binding by ATP causes the heterodimer to 
translocate along the DNA in a mechanism driven by ATP hydrolysis, similar to the 
process as demonstrated in E. coli (91, 125, 127). In in vitro experiments the 
translocation results in hM utSa falling off of the relatively small oligonucleotide 
substrates used. Evidence for this model includes kinetic analysis suggesting that simple 
diffusion is unlikely to be the mechanism for the heterodimers release (127). ATP 
hydrolysis and not ATP binding has also been shown to be involved in the rate 
determining repair step (125). As well, experiments using end-blocked substrates have 
demonstrated that these inhibit hM utSa release from the oligonucleotide (125). The 
suggested model is that ATP binding reduces the affinity o f the hM utSa heterodimer for 
a mispair, but activates secondary DNA binding site(s) that are used to move the protein 
along the helix in a reaction that is dependent on ATP hydrolysis. Although the details of 
ATP action on hM utSa are currently hotly debated it is clear that ATP binding results in 
a conformational change which affects DNA interactions, protein interactions and 
subsequent steps in the repair process.
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HNPCC kindreds with mutations in the gene for hMSH6 have been found, but 
there are only two known families making this extremely rare (128 - 130). As well, study 
of hMSH6 deficient cell lines has shown that the mutator phenotype is not as pronounced 
as in hMSH2 deficient cells (4, 129). This genetic evidence is now believed to be 
explained by a functional redundancy in the MutS homologs, with hMSH2 able to pair 
with hMSH6 to form the hM utSa heterodimer or with hMSH3 to form the hMutS(3 
heterodimer (109, 131). In vitro, hMutS(3 has been shown to bind with greatest affinity to 
insertion-deletion loops of up to 16 bases although it can also bind to some extent to the 
various mismatches (132 -  134). Studies have also demonstrated that hMutSP 
specifically supports the repair of insertion/deletion loops of 2 - 8 nucleotides (131) and 
as well, the hMutS(3 complex been shown to be modulated by ATP binding, similar to 
hM utSa (135). As of yet there are no known reports of HNPCC kindreds with mutations 
in the gene for hMSH3 (11) and MSH3 deficiency has been shown to not result in a 
mutator phenotype in Chinese hamster ovary cells (136). However, overexpression of the 
gene did result in mismatch repair deficiency in human cell lines (137). This suggests 
that hMSH2 partitions between available pools of hMSH3 and hMSH6. The binding 
specificities of the various MutS homologs and the genetic evidence suggests a central 
role for hMSH2 (hence the large number of HNPCC kindreds). hMSH6 and hMSH3 
appear to have partially overlapping functions, with hM utSa (hMSH6) believed to be 
primarily responsible for initiation of repair of mismatches and hMutSp (hMSH3) 
believed to function in repair of most insertion-deletion errors.
Two other MutS homologs have recently been described in humans; hMSH4 and 
hMSH5 (138 - 140). hMSH5 is expressed in greater amounts in meiotic tissue (141, 142) 
and based on yeast genetic evidence does not appear to function in mismatch repair (138, 
143). In mouse cells, mutations in MSH5 result in meiotic defects (144). In 
Saccharomyces cerevisiae, MSH4 and MSH5 have been shown to be required for 
crossing-over during meiotic recombination (138, 139, 143). Based on this evidence it 
appears that hMSH4 and hMSH5 have specialized functions in recombination events, 
perhaps acting with hMLHl, with which they have been reported to interact (145). A 
human homolog to the yeast M SH1 mitochondrial mismatch repair protein has not yet 
been reported (81, 105).
c. Human MutL homologs
The human MutL homologs hMLH 1, hPMS2 and hPMS 1 are also required for 
mismatch repair (for reviews see 81). Approximately 61% of HNPCC kindreds contain 
mutations in the hMLHl gene (11, 146 - 148), implying a central role for hMLHl in 
mismatch repair. Interestingly, hMLHl promoter hypermethylation has also been 
detected in spontaneous tumors displaying microsatellite instability (149, 150). This 
methylation has been shown to correlate with a lack of hMLHl expression demonstrating 
that epigenetic events can also lead to aberrant expression of this mismatch repair gene 
and the mutator phenotype (151, 152). As with the MutS homologs, the MutL homologs 
appear to function as heterodimeric complexes in 1:1 ratios. Cells mutated in these genes 
display a similar microsatellite instability and a mutator phenotype and extracts from
such cells are defective in repair of mismatches and small insertion/deletion loops (10,
153 - 157). Unfortunately, as with bacteria very little is known in regards to the exact 
roles and biochemical functions of the MutL homologs in human cells.
What is known is that a protein fraction consisting of a heterodimer of hPMS2 
and hMLHl is capable of restoring mismatch repair activity in nuclear extracts from 
human cancer cells that are hMLHl deficient (158), suggesting the existence of a 
hM utLa heterodimer of hMSHl and hPMS2. In addition, a heterodimer of hPMSl and 
hMLHl (hMutL(3) has recently been reported (159). Currently there is one HNPCC 
family known to harbor a mutation in the hPMSl gene and two cases linked to mutations 
in the hPMS2 gene (146, 11). Based on this biochemical and genetic evidence it has been 
proposed that, as with the MutS homologs, there exists functional redundancies between 
hPMS2 and hPMSl with both binding to hM LH l. One obvious possibility would be that 
one of the MutL heterodimers is primarily responsible for repair of mismatches with 
hM utSa while another is primarily responsible for repair of insertion-deletion loops with 
hMutSP, with some overlap of function. In support of this model, in S. cerevisiae the 
homologue of hPMSl (confusingly called PMS2) has been shown to interact with MLH1 
in the two-hybrid assay (160) and to contribute specifically to repair of a subset of 
insertion/deletion loops (161). Evidence against such a model comes from genetic 
studies which have shown the mutator phenotype of hMLHl deficient cells to be similar 
to that of cells deficient in hPMS2 or hPMSl (81). This would not be expected if there 
was some overlap of function. Clarifying the protein-protein interactions between the
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MutL homologs and determining the biochemical functions for these essential proteins is 
one of the current challenges in the field of mismatch repair.
d. Interactions between the MutS and MutL homologs
Based on the E. coli model (see above and Figure 3), it is hypothesized that the 
MutS and MutL homologs interact in the eukaryotic mismatch repair process. The first 
study to show this utilized yeast purified proteins (162). In this study it was 
demonstrated by gel-shift analysis that MSH2, MLH1 and PMS1 (homologous to human 
PMS2) interact. However, the relevance of this finding is in question as subsequent 
studies demonstrated that MSH2 does not function primarily as a homodimer, but instead 
exists as a heterodimer with MSH6 or MSH3. Other studies in yeast using purified 
proteins have shown that MSH2, MSH6, MLH1 and PMS1 interact in gel-shift studies 
and that the MLH1-PMS1 complex enhances binding of the MSH2-MSH3 heterodimer to 
insertion-deletion loops (163, 164). Recently, in human nuclear extracts the hPMS2 and 
hMSH2 proteins were shown to co-immunoprecipitate with hM LHl in the presence of 
heteroduplex DNA (165). Unfortunately this study did not report on the presence of 
hMSH6 or hPMS 1. Therefore, although it appears that the MutS and MutL mismatch 
repair protein homologs interact with each other, a comprehensive examination has been 
until now lacking in the literature.
Although the role of ATP binding and hydrolysis has been extensively studied 
using purified hM utSa, the role of ATP in the eukaryotic MutS/MutL interactions is 
currently unclear. In the gel-shift studies utilizing yeast purified proteins, MHS2, MLH1
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and PM S1 were shown to interact both in the presence and absence of additional ATP 
(162). Once again the caveat for these studies is that they did not include MSH6 or 
MSH3. In other studies using yeast purified MSH2, MSH6, MLH1 and PMS1, the 
higher-order complex only formed in the presence of ATP (163, 164). In human nuclear 
extracts, the co-immunoprecipitation o f hPMS2 and hMSH2 with hMLHl was observed 
to occur only in the presence of ATP (165). It has been suggested that the MutL 
homologs could act to modulate the ATPase activity of the hM utSa heterodimer, similar 
to how GAP proteins modulate GTP hydrolysis in G-proteins. Alternatively, they could 
function in steps of DNA mispair correction subsequent to mismatch recognition, such as 
in strand discrimination, translocation or binding of exonucleases. It is also quite 
possible that the MutL homologs possess an as yet unidentified ATPase activity, similar 
to that recently demonstrated in E. coli MutL (103, 104).
e. Other proteins involved in eukaryotic mismatch repair
A number of other proteins have been identified as being required for eukaryotic 
mismatch repair. PCNA appears to be one of these. From biochemical studies it is 
required both in the early stages of repair and during replication, presumably in this latter 
case in its usual role in polymerase processivity (166). PCNA mutants display a mutator 
phenotype similar to those of the mismatch repair protein mutants (167) and PCNA has 
been shown to co-immunoprecipitate with the mismatch repair proteins in human nuclear 
extracts (165). As in E. coli a number of partially redundant exonucleases also appear to 
function. One of these is probably exonuclease 1. It has been shown to physically
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interact with hMSH2 in human nuclear extracts (168) and in yeast genetic studies 
mutants in the gene for exonuclease 1 have a weak mutator phenotype that acts in the 
same epistatic pathway as MSH2 (169, 170). Another candidate for a mismatch repair 
exonuclease is the yeast FEN 1 (RAD27) protein. This has been shown in two-hybrid 
studies to interact with PCNA (171) and mutants display an increased occurrence of 
frameshift mutations similar to that seen in MHS2 mutants (171). From fractionation 
experiments DNA polymerase 5 also appears to be required (172). Similarly, 
immunodepletion and reconstitution experiments have demonstrated that single-stranded 
binding protein and RPA are required in vitro in mismatch repair (173). It also seems 
likely that RFC will be found to be required as it is generally necessary for PCNA 
loading onto DNA. This list of required proteins is certainly not complete. For instance, 
a DNA helicase and a 3’ ->  5’ exonuclease has yet to be identified, although DNA 
polymerase 8 could possibly provide the latter function. DNA ligase I is also likely to be 
involved in mismatch repair as it is frequently associated with DNA polymerase 8 and 
PCNA-dependent replication.
f  Strand discrimination
Another as yet unresolved question in the field o f mismatch repair is the nature of 
the strand discrimination signal in eukaryotic cells. In E. coli the hemi-methylated state 
of the DNA that occurs immediately after replication serves as the strand discrimination 
signal with the MutH-associated endonuclease nicking the newly synthesized, 
temporarily unmethylated strand (83). Vertebrates and plants also methylate their DNA,
primarily at the 5’ position of cytosine in CpG or CpXpG motifs. One report from 1985 
(174) suggested that such sites could direct repair. However, a methylation based strand 
discrimination system seems unlikely as these results have not been duplicated and the 
patterns of methylation in higher organisms are highly irregular with stretches of up to 
several kb remaining unmethylated. Attempted mismatch repair in such areas would lead 
to an unacceptable level of mutation due to undirected repair. As well, many lower 
eukaryotes such as S. cervisiae and Drosophila melongaster lack methylation altogether 
but have functional mismatch repair systems. Finally, MutH-like methylation-sensitive 
endonucleases have not been found in any of the numerous organisms whose genomes 
have been or are being studied, even in other microorganisms such as Streptococcus 
pneumoniae (82). It appears that methylation-based strand discrimination, although 
elegant, is the exception rather than the rule.
What is known is that the mismatch repair process can be directed in all systems 
(including E. coli) by a nick on the strand containing the mismatch (175, 176). Circular 
substrates containing mismatched nucleotides but lacking a nick have been found to be 
refractory to strand specific mismatch repair, both in vitro (175, 176) and in vivo (177, 
178). Experiments using human cell extracts have demonstrated that pre-existing nicks 
on the same strand of DNA as the incorrect base, located either 5 ’ or 3 ’ to the mismatch, 
can direct repair and that the strand-break can be as many as 1000 base pairs away from 
the mismatch (175, 176). As such nicks are present in recombination intermediates they 
could serve to direct repair in this instance. As for post-replicative repair, nicks or gaps 
that can direct repair will also occur between neighboring Okazaki fragments on the
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lagging strand. The leading strand, however, presents a difficulty. Currently a 
commonly proposed theory is that the mismatch repair proteins are directly associated 
with the replication apparatus at the replication fork, thus dispensing of the need for a 
separate strand discrimination signal. Evidence supporting this hypothesis comes from 
yeast two-hybrid studies where PCNA, a protein known to interact with DNA 
polymerases, was demonstrated to interact with MLH1 (167). Immunoprecipitation 
studies using human nuclear extracts have also demonstrated an interaction between 
hMLHl, hMSH2 and PCNA (165). These findings suggest a model whereby the PCNA 
homotrimers link the polymerase with the mismatch repair proteins. Also supporting this 
are studies in yeast which have shown PCNA to be required in a step prior to re­
synthesis, and thus to have a role other than its standard role in facilitating processivity of 
replication (166). It is also possible that mismatch repair functions at times in the cell 
cycle other than immediately post-replication although potential strand discrimination 
signals for this are unknown. Hopefully, by clarifying the protein-protein interactions 
between the mismatch repair proteins and by identifying their biochemical functions the 
mechanism of strand discrimination in organisms other than E, coli will be understood.
g. Other functions o f  the mismatch repair proteins
A number of studies have suggested that there are links between mismatch repair 
and transcription-coupled repair. The first study to suggest this demonstrated that in E. 
coli mutations in MutS or MutL abolished transcription-coupled repair o f UV 
photoproducts (179). Subsequent research using human cell lines showed that
transcription-coupled repair of UV damage was abolished in humans cells lacking 
hMSH2, hPMS2 or hMLHl and that the repair could be restored by appropriate 
chromosome transfer (180, 181). Interestingly, the levels of global nucleotide excision 
repair in the cells studied remained unaffected. When repair of oxidative DNA damage 
was examined it was found that only hMSH2 mutants (and not hMLH 1, hPMS2 or 
hMSH6) were deficient in transcription-coupled repair (181). Such discrimination in 
types o f damage recognized has led to the suggestion that the mismatch repair enzymes 
function in the damage recognition steps o f transcription-coupled repair. Recently, a 
physical interaction between MSH2 in yeast and a number of nucleotide excision repair 
proteins was demonstrated using the two-hybrid screen (182). There appears to be an 
overlapping of function in the transcription-coupled repair and mismatch repair 
pathways. Alternatively, components from each pathway could function together in an as 
yet unknown manner.
The mismatch repair proteins have also been suggested to play a role in damage 
recognition at the G2 -M checkpoint and in induction of apoptosis. This concept first 
developed from studies using methylating agents, where it was shown that MSH2 
deficient cells display increased survival rates (183, 184). These agents normally trigger 
an apoptotic response after G2 -M arrest in normal cells. Failure to detect the damage and 
hence trigger apoptosis would lead to the observed increased survival rates, thus 
suggesting a role for hMSH2 or more generally the mismatch repair proteins, in apoptosis 
and the G2 -M checkpoint. It has subsequently been shown that cell lines deficient in 
hM utSa or hM utLa (but not hMutS(3) fail to elicit a G2 checkpoint arrest upon treatment
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rwith methylating agents (185 - 187). Response to other DNA damaging agents such as 
cisplatin, 6-thioguanine and doxorubicin also appears to depend on a functional mismatch 
repair system (184). One suggestion is that hM utSa may function in recognition of DNA 
damage prior to cell cycle arrest. In support of this hypothesis, hMutSa has been shown 
to directly bind to cisplatin lesions, 0 6-methylguanine residues, 0 4-methylthymine 
residues, aminofluorene adducts, acetylaminofluorene adducts and pyrimidine dimers, 
providing physical evidence for a role in damage recognition (188-191). It has also 
been proposed that the sensitivity to DNA damaging agents is caused by futile cycling of 
mismatch repair. This repair either results in repeated removal of the nucleotide opposite 
the lesion, and thus futile cycling, or to potentially lethal double-stranded breaks that 
result in cell cycle arrest (184).
In conjunction with a putative role in damage recognition, the mismatch repair 
proteins may also have a more direct role in the induction o f apoptosis. Studies in 
knockout mice found that MSH2 is involved in vivo in initiation of apoptosis (192). In 
vitro, cells deficient in human MutS or MutL homologs were unable to induce cell death 
after damage by a variety of chemical carcinogens (193). From genetic analysis in yeast 
and studies o f p53 expression, this appears to be mediated through both a p5 3-dependent 
pathway and a delayed p53-independent apoptotic pathway (193, 194). Other researchers 
have demonstrated that hMutSa and hM utLa are required for phosphorylation of p53 in 
response to DNA methylation damage, presumably through activation of one or more 
protein kinase (195). Stabilization of p53 and apoptosis induction can result from 
overexpression o f hMSH2 or hMLHl (but not hMSH3, hMSH6 or hPMS2) (196). These
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results implicate the mismatch repair system in the initial steps o f a damage-signaling 
cascade that can lead to cell cycle arrest or cell death, although this hypothesis has been 
challenged. This may have significant clinic implications in that hMSH2 deficiencies 
(and possibly deficiencies in other mismatch repair proteins) can lead to malignancy not 
only through failure to repair mismatched nucleotides, but also through failure to initiate 
apoptosis. Therefore, hMSH2 deficient tumors are likely to be resistant to treatment by 
many standard chemotoxic agents.
Finally, research has suggested roles for the mismatch repair proteins in a number 
of disparate cellular functions. Studies in S. cerevisiae and in transgenic mice have 
indicated that hM LHl functions directly in meiotic recombination (145, 197). Repair of 
branched structures in yeast also appears to require mismatch repair homologs with 
MSH2, MSH3 and MSH6 shown to be required for certain types o f recombination (198, 
199). Similarly, deficiencies in hPMS2 were reported to affect the rates of somatic 
recombination in human cells (200). These studies imply a central role for the mismatch 
repair protein in DNA metabolic pathways.
C. Hotspots o f  Mutation and Mismatch Repair
It has been well documented that the frequency and spectra o f tumor-associated 
mutations are not random. Indeed, recent reviews have suggested that a major portion of 
human gene mutations are found at mutagenic hotspots, similar to the mutational spectra 
seen in bacteria (201, 202). The ras genes are a prime example o f this phenomena. The
ras oncogene codes for a G-protein with a central role in at least three different signal 
transduction cascades controlling cell growth and differentiation (for reviews see 203, 
204). When bound to GDP, Ras is in the ‘o ff  state and cannot activate its downstream 
effectors. When GDP is exchanged for GTP, Ras is ‘on’ resulting in activation of the 
signal transduction cascades. This ‘on’ state is normally transitory as Ras has an intrinsic 
GTPase activity, which together with external GTPase activating proteins (GAPs) 
ensures that the signal is rapidly turned off by hydrolyzing the GTP to GDP. Thus the 
Ras protein functions as a molecular switch for signal transduction. Screening of human 
tumors has revealed the apparently ubiquitous nature of mutated ras genes in cancers and 
has shown that ras mutations are the most common abnormality of a dominant oncogene 
in human tumors (for reviews see 201, 203, 204). Direct sequence analysis has 
demonstrated that there are activating mutations in the ras oncogene family in nearly 
30% of human tumors (203 - 205). Intriguingly, these mutations occur exclusively in 
codons 12, 13 and 61 (203 - 205). Clearly, a better understanding of the mechanisms 
responsible for such precise mutagenic targeting is important for our understanding of the 
processes responsible for cell transformation to the neoplastic phenotype.
Three general hypotheses have been put forward to explain tumor-associated 
hotspots of mutation. The first hypothesis is that activating mutations are selected for 
due to the increased survival rates that they confer. Although this may indeed be a 
causative factor in the prevalence of some activating hotspots o f mutation in tumors it 
does not explain all cases. For example, several additional activating mutations in the ras 
genes besides codon 12, 13 and 61 have been found in vitro that have never been found in
vivo in human tumors or animal model studies (203 - 205). Therefore, the selective 
advantage conferred by an activating mutation is not a sufficient explanation for the 
existence of these tumor-associated hotspots of mutation.
Secondly, hotspots could occur due to an increased susceptibility of specific DNA 
sequences to damage. A number of studies, both in vitro and in vivo have shown that 
precise mutagen targeting does occur (for review see 206). For example, numerous 
animal model studies have demonstrated correlations between type of chemical exposure 
and location and type of ras activating mutations in resultant tumors (203, 207). As well, 
recent studies have shown preferential binding by carcinogens and formation of 
benzopyrene adducts at mutational hotspots in the p53 tumor suppressor gene (208, 209). 
These studies clearly demonstrate that mutagen induced lesions can be targeted to 
specific sequences and that some hotspots are particularly susceptible to DNA damage.
A third hypothesis to explain mutagenic hotspots is that there is decreased fidelity 
of repair and/or inefficiencies in repair at specific sequences. This can occur either 
during the replication process or afterwards in post-replicative repair. For example, an 
inability of the DNA polymerases to perform their 3’->  5’ exonuclease proofreading 
functions at a specific location would affect repair rates. Indeed, primer extension studies 
have indicated that polymerase a  pausing at the H-ras codon 12 hotspot of mutation is 
abolished when the template is mutated, perhaps reflecting an inability of the polymerase 
to proofread misincorporations at this hotspot (210). Post-replicative repair processes can 
also vary depending on the location of the damage. A number of studies have clearly 
demonstrated that there is a heterogeneity in the nucleotide excision repair process at the
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gene level (211 - 213). Nucleotide excision repair of pyrimidine dimers and benzopyrene 
adducts has been shown to occur correctly, but more slowly, at mutational hotspots in the 
p53 tumor suppressor gene (214, 215). As well, results from studies examining repair of 
inserted guanine adducts at different positions in codon 12 or 13 of H-ras have suggested 
that nucleotide excision repair rates vary at different locations (216-218). These studies 
indicate that there are site-specific inefficiencies in repair that could result in hotspots of 
mutation.
These hypotheses attributing different causative events to the process of increased 
mutation at hotspots are not mutually exclusive. It seems quite likely that hotspots can 
occur due to an increased propensity to DNA damage and a decreased ability to repair 
that damage and that they are then found in tumors due to the oncogenic phenotype that 
they help confer. For example, in p53 several hotspots at activating locations have been 
shown to be more susceptible to damage and more slowly repaired (208, 209, 216 -218). 
Thus, a combination of events can contribute to the significantly increased frequency of 
mutation observed at specific locations.
Another factor that is believed to influence the frequency of mutation at a 
particular site is the sequence context surrounding that site. This was initially shown in
E. coli in studies examining adduct-induced frameshift mutations (219). Once again, 
mutations can occur due to increased damage at a particular site or due to decreased 
fidelity or efficiency of repair, both during and after replication. A number of studies 
have shown that the surrounding sequence context can affect the rate of damage to a site 
(219 - 222). The surrounding sequence context has also been shown to affect the rate of
mutagenic bypass by DNA polymerase in vitro (223 - 225). Finally, post-replicative 
repair of bulky lesions has also been shown to be influenced by the surrounding 
nucleotides in both E. coli and eukaryotic cells (211,212, 226). It appears that 
surrounding sequence context profoundly affects the rate of mutation, regardless of the 
reason or reasons for a particular hotspot.
The importance of understanding mechanisms of site-specific mutation is 
demonstrated by the prevalence of hotspots of mutation in naturally occurring tumors. 
Also, the importance of the mismatch repair system in genome stability and prevention of 
mutation has been clearly shown, both in spontaneous tumors and in HNPCC kindreds 
(10, 12, 14). Previous results from our laboratory have indicated differences in mismatch 
repair rates for various mismatches at the codon 12 hotspot o f mutation in H-ras (227). 
We theorized then that there might be an overall decrease in mismatch repair at the codon 
12 location as compared to other non-hotspots of mutation. Such defects in mismatch 
repair in otherwise repair proficient cells could affect the frequency and spectra of 
mutation. Therefore, the goal of the studies presented here was to determine if inefficient 
or incorrect repair of mismatches can play a role in mutagenesis at a tumor-associated 
hotspot in individuals who do not carry germ-line mutations in one of the genes coding 
for mismatch repair proteins. The exact interactions between the mismatch repair 
proteins and DNA substrates, both at hotspot locations and at non-hotspots were then 
systematically determined.
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II. Materials and Methods
A. Enzymes, Antibodies and Reagents
All site-specific mismatch, synthetic oligonucleotides were purchased from 
Operon Technologies Inc. Amplitherm DNA Polymerase was purchased from Epicentre 
Technologies Corporation. T4 polynucleotide kinase for immunoprecipitation 
experiments and NaeI and Nar\ restriction endonucleases were purchased from Promega 
Corporation. Hindlll, A fllll and Pvul restriction endonucleases were purchased from 
New England Biolabs. Xhol and Kpnl restriction endonucleases and T4 DNA ligase were 
purchased from Boehringer Mannheim, Inc. T4 polynucleotide kinase for gel-shift 
experiments, Shrimp Alkaline Phosphatase (SAP) and Exonuclease I (Exol) were 
purchased from USB Corporation. Thermosequenase, dNTPs, Protein-G Sepharose 4 
Fast Flow, streptavidin-horseradish peroxidase, anti-mouse immunoglobulin antibody 
and ECL Western blotting detection kits were purchased from Amersham Pharmacia 
Biotech. Radioactively labeled nucleotides were purchased from NEN Life Science 
Products, Inc. SeaKem GTG agarose, SeaPlaque agarose and NuSieve 3:1 agarose were 
purchased from FMC BioProducts. DH5a competent E. coli cells, Dulbecco’s Modified 
Eagle Medium (DMEM; 4.5 g/L glucose), LipofectAMINE transfection reagent, and 
OptiMEM medium were purchased from Gibco BRL Life Technologies, Inc. NIH 3T3 
cells were obtained form the American Type Culture Collection. Bovine calf serum was 
purchased from HyClone Laboratories, Inc. Hygromycin B was purchased from
Calbiochem-Novabiochem Corporation. BioMax autoradiography film was purchased 
from Eastman Kodak Corporation. Antibodies against hMSH2 (monoclonal) were 
purchased from Oncogene Research Products. Antibodies against hMSH6 (polyclonal), 
hMLHl (polyclonal) hPMS2 (polyclonal) and hPMSl (polyclonal) were purchased from 
Santa Cruz Biotechnology. Sigma-Fluor liquid scintillation cocktail, Sephadex G-25, 
Sephadex G-50, carbenicillin and all other reagents were purchased from Sigma 
Chemical Company unless otherwise noted.
B. Plasmid and M l 3 Constructs
Prior to these studies the following steps were taken to produce the plasmids and 
M l3 bacteriophage constructs used in the mismatched plasmid preparation (227, 228). 
First, a shuttle vector containing human H-ras genomic DNA was constructed by 
inserting the wild-type (wt) human H-ras genomic sequence (BamWl 6.4 kb segment 
from pbc-Nl) into the BamHl site in the polylinker region of the Epstein Barr Virus 
(EBV) shuttle vector p220.2. Removal of the original Hindlll site in the polylinker 
region of p220.pbc was then accomplished by DNA polymerase I (Klenow fragment) 
5’->  3’ exonucleolytic digestion and subsequent blunt-end ligation by the standard 
procedure (229) to produce the p220.pbc-H/B plasmid (see below for description of 
-H/B). A 2 kb BamHl-Kpnl segment of p220.pbc-H/B containing exon 1 was ligated 
into the polylinker region of bacteriophage M13mpl9 and subjected to oligonucleotide- 
directed mutagenesis to create two new restriction enzyme recognition sites, Hindlll and
Bst98l, 30 basepairs (bp) apart flanking H-ras codon 10 and codon 12 in exon 1. Three 
separate rounds of oligonucleotide-directed mutagenesis were performed with the M 13- 
ras plasmid to change a total o f four bases: codon 6, G ->  T (no amino acid change to 
create a unique Hindlll site) and codon 15, GGC ->  CTT (Gly ->  Leu, both neutral non­
polar amino acids to create a unique Bst9Sl site). Restriction digestion and dideoxy 
sequencing were used to select M13-ras clones that contained only the above indicated 
base changes. The BamHl-Kpnl segment containing the new sites was excised from 
double stranded M13-ras DNA and re-inserted into p220.pbc-H/B to replace the original 
2 kb H-ras segment, producing the modified plasmid p220.pbc+H/B. The 2 kb BamHl - 
Kpnl segment o f the H-ras gene containing codon 10 and codon 12 was then isolated 
from the p220.pbc+H/B plasmid and ligated into the polylinker region of pUC19 , 
M 13mpl8 and M13mpl9 to produce prasBK2.0, M 13rasl8.9 (+ strand contains non­
coding sequence from H-ras) and M13ras 19.1(+ strand contains coding sequence from 
H-ras), respectively.
C. Heteroduplex Preparation for Mismatch Repair Analysis
To create heteroduplex DNA, 100 jig of the prasBK2.0 plasmid was initially 
digested with 1.5 units enzyme/jig DNA each of Afllll (New England Biolabs) and Pvul 
(New England Biolabs) at a final DNA concentration of 0.20 |ig/|J.l to release a 2.5 kb 
fragment containing the inserted H-ras segment. The products from this reaction were 
next digested with Bst9$l (Promega Corporation) in a final DNA concentration of 50
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ng/^il using approximately 10 units enzyme/p-g DNA. The digest was checked by gel 
electrophoresis and repeated if the reaction was not judged as complete by the 
disappearance of the 2.5 kb band and the appearance of a 2.1 kb band. The products from 
the Bst98\ digest were then digested with Hindlll (New England Biolabs) using 
approximately 10 units enzyme/|ig DNA in a final concentration o f 50 ng/(xl to produce a 
unique 1.7 kb fragment. The four restriction enzyme digestions selectively excise the 30 
bp segment containing codon 10 of H-ras from the ras containing segment (Figure 4,
Step 1).
Mismatch oligonucleotides complementary to the 30 bp region spanning codon 10 
were obtained from Operon Technologies Inc. Coding strand oligonucleotides had the 
sequence o f 5 ’-AGCTTGTGGTGGTGGGCGCCGGCGGTGTGC-3 ’ with the bolded G 
replaced with T to produce T:C mismatches or A to produce A:C mismatches at codon
10. Non-coding strand oligonucleotides had the sequence of 5’-
TTAAGCACACCGCCGGCGCCCACCACCACA-3’ with the bolded C replaced with T 
to produce G:T mismatches or with A to produce G:A mismatches at codon 10. 
Oligonucleotides were phosphorylated using T4 polynucleotide kinase (USB 
Corporation) at a final DNA concentration of 0.125 fxg/^il using 16 units enzyme/^ig 
DNA as described by the manufacturer. The reactions were incubated at 37°C for 60 
minutes and then spun through a Sephadex G-50 column (Sigma Chemical Company) 
equilibrated in dH20 at 300 x g for 3 minutes.
The phosphorylated mismatch oligonucleotides were annealed with the 
complementary single stranded M l3ras DNA and the fragments from the
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Figure 4 -  Mismatch Plasmid Construction See text for description of processes
Afllll!Pvul! Bst9%HHindlll digested pra.s-BK2.0 at a 50:1:1 molar ratio of 
oligonucleotides:M13ras:fragments (Figure 4, Step 2). This reaction was carried out in a 
final volume of 50 jal at a final DNA concentration of 45 ng/|J.l in 40 mM Tris (pH 7.6), 
50 mM MgCh, 50 mM NaCh. The fragments were heated to 100°C for 8 minutes (min) 
and then cooled to 80°C over 2 min. During the last 30 seconds of this cooling period the 
M13ras, annealing buffer and mismatch oligonucleotides were added. The reaction was 
then allowed to cool to 65°C over 30 minutes and held at 65°C for an additional 30 
minutes before cooling to 2°C. Generation of heteroduplex DNA was made according to 
choice of mismatch 30-mer oligonucleotide and single-stranded M13ras complementary 
DNA. Use of single-stranded M B ras  18.9 (non-coding strand) and the appropriate 
mismatch-containing oligonucleotide based on the coding strand resulted in T:C and A:C 
mismatches. Use of single-stranded M13rasl9.1 (coding strand) and the appropriate 
mismatch-containing oligonucleotides based on the non-coding strand resulted in G:T or 
G:A mismatches.
The partially double stranded M13ras molecule was next cleaved with Xhol and 
Kpnl using 10 units of each enzyme/jig DNA at a final DNA concentration of 100 ng/jal 
to produce a unique 1.8 kb double stranded fragment (Figure 4, Step 3). The reaction 
contents were subjected to 1% gel electrophoresis through a SeaPlaque gel (FMC 
BioProducts) and the 1.8 kb fragment was isolated using the Qiaquick Gel Extraction Kit 
as described by the manufacturer (Qiagen, Inc.).
To ensure that the mismatch-containing oligonucleotide was indeed present, 
excess mismatch-containing oligonucleotide was again annealed to the fragment.
Oligonucleotide and the 1.8 kb fragment were mixed together at a 200:1 molar ratio of 
oligonucleotide: 1.8 kb fragment at a DNA concentration of 50 ng/(il in a buffer 
consisting of 50 mM Tris-HCl (pH 7.6), 10 mM dithiothreitol, 500 Hg/ml bovine serum 
albumin. The mixture was placed in a 2-liter beaker of water at 85°C and allowed to cool 
overnight to room temperature (Figure 4, Step 4). The 1.8 kb fragment was then ligated 
to the 13.5 kb Xhol-Kpnl vector portion of the original p220.pbc-H/B plasmid at a 3:1 
molar ratio of fragment:vector using 0.5 units T4 DNA Ligase (Boehringer Mannheim 
Corporation) per |ig DNA as described by the manufacturer. The 13.5 kb vector was 
produced by digesting p220.pbc-H/B with 10 units/|ig DNA each of Xhol and Kpnl at a 
final concentration of 100 ng/jal. The digestion reaction products were then run overnight 
at low voltage on a 0.7% SeaKem GTG gel (FMC BioProducts) and the 13.5 kb band was 
excised and purified using the Qiaquick Gel Extraction Kit as described by the 
manufacturer (Qiagen, Inc.). The vector contains the remaining H-ras genomic 
sequence, Epstein-Barr virus (EBV) origin of replication, eukaryotic hygromycin 
resistance, bacterial carbenicillin resistance and bacterial replication sequences (230).
The final ligation step produces a p220pbc+H/B plasmid containing a site- and strand- 
specific mismatch at H-ras codon 10, middle base pair (Figure 4, step 5). This 
heteroduplex is easily distinguished from any undigested vector (p220.pbc-H/B) by the 
presence of the Hindlll and 5sf98I sites.
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D. Cell Lines and Transfection
D H 5a competent E. coli cells were transformed with 50 ng of mismatch 
containing plasmid as described by the manufacturer (Gibco BRL Life Technologies, 
Inc.). Bacteria were grown overnight at 37°C on LB agar plates containing 75 (xg/ml 
carbenicillin. NIH 3T3 cells were grown in DMEM, 10% calf serum at 37°C, 5% CO2 . 
Cells were seeded at 1 x 106 per 100 mm plate in preparation for transfection experiments 
16-18 hours (hr) later. For each plate 100 ng of plasmid DNA was added to 670 |0,1 of 
OptiMEM media (Gibco BRL Life Technologies, Inc.) and 30 (il o f LipofectAMINE 
transfection reagent and incubated for 40 min at room temperature. The cells were 
placed into OptiMEM media and the plasmid mixture was added evenly to each plate.
The plates were then placed at 37°C with gentle rotation for 30 min and then at 37°C, 5% 
CO2 for 5 hr 30 min without agitation. At this time the OptiMEM media was removed 
and replaced with DMEM, 10% calf serum. NIH 3T3 hygromycin resistant cells were 
subsequently selected for by the addition of 125 units o f hygromycin (Calbiochem- 
Novabiochem Corporation) per ml of media, starting 36 hr after transfection. At the end 
of 3 weeks, hygromycin resistant colonies on each plate were methanol (97%) fixed and 
stained using 1% crystal violet, 20% ethanol.
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E. Mismatch Repair Analysis
To analyze repair o f mismatches in vivo in NIH 3T3 cells, DNA was purified 
from each hygromycin-resistant colony. Cloning cylinders (Bellco Glass, Inc.) were 
adhered to the culture dish surrounding each colony using sterile silicone vacuum grease. 
A 100 (xl aliquot o f lysis buffer (10 mM Tris-HCl (pH 8.3), 50 mM KC1, 0.1 mg/ml 
gelatin, 0.45% NP-40, 0.45% Tween 20, 2.5 mM MgC^) containing 12 (ig Proteinase K 
(231) was added to the cloning ring and incubated for 10 min at room temperature. Each 
solution was then repeatedly aspirated to dislodge remaining cells from the culture plate, 
transferred into a 0.5-ml microcentrifuge tube and incubated for 1 h at 55°C followed by 
10 min at 95°C. Samples were extracted once with 2 volumes (vol) of 
phenol:chloroform:isoamyl alcohol (25 vol:24 vol:l vol, Sigma Chemical Company), and 
precipitated overnight at -20°C with 1/10 vol of 3 M sodium acetate and 2 vol ethanol. 
The DNA pellets were isolated by centrifugation for 30 min at 1,200 x g and then dried 
by centrifugation under a vacuum with heat for 20 min. The DNA lysates were then 
resuspended in 10 (0.1 of sterile dH20.
To purify DNA from carbenicillin resistant D H 5a colonies, cells from each 
colony were removed from the plates using sterile toothpicks and placed in 0.5-ml 
microcentrifuge tubes. 100 |u,l of the lysis buffer (10 mM Tris-HCl (pH 8.3), 50 mM 
KC1, 0.1 mg/ml gelatin, 0.45% NP-40, 0.45% Tween 20, 2.5 mM MgCl2,12 ^g Proteinase 
K) was added to the microcentrifuge tubes and they were incubated for 1 h at 55°C 
followed by 10 min at 95°C. Samples were then extracted once with 2 vol of
phenol:chloroform:isoamyl alcohol (25 vol:24 vol:l vol, Sigma Chemical Company), and 
precipitated overnight at -20°C with 1/10 vol of 3 M sodium acetate and 2 vol ethanol. 
The DNA pellets were isolated by centrifugation for 30 min at 1,200 x g and then dried 
by centrifugation under a vacuum with heat for 20 min followed by resuspension in 10 p,l 
of sterile dEbO.
A 5-jxl aliquot from each DNA lysate was PCR amplified using 2.5 units of 
Amplitherm enzyme (Epicentre Technologies) per reaction in the supplied buffer plus 
0.5-5 mM MgC^ (optimized for each preparation), 200 jiM of each dNTP and 100 ng of 
each primer in a final volume of 100 jxl, with the amplitherm enzyme separated from the 
other reactants by a wax layer (Chill-Out 14, MJ Research, Inc.). The reactions were 
heated to 96°C for 3 min followed by 35 cycles of 40 seconds at 96°C, 40 seconds at 
62°C and 1 min at 72°C. The samples were then incubated for 7 min at 72°C to allow 
completion of extension reactions and cooled to 4°C. PCR primers used for DNA 
amplification were: 5’ H-ras ->  5’-TGAGGAGCGATGACGGAATAT-3’ and 3’ H-ras 
-> 5 ’-CAGGCTCACCTCTATAGTGGGGTC-3\ yielding an amplified DNA product of 
129 bp containing exon 1 of human H-ras plus several base pairs o f human intronic 
region surrounding exon 1, thus precluding amplification o f NIH 3T3 genomic DNA. 
Negative controls (no DNA added to PCR amplification reaction) were added to each 
experiment and correct amplification was checked by electrophoresis on a 2% SeaKem 
GTG gel (FMC BioProducts) (see Figure 5A).
To confirm that each sample did not result from transfection of undigested vector 
(p220.pbc-H/B), 20 p.1 of each PCR amplified product was purified with Qiagen’s PCR
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Uncut 129 bp 
fragm ent_   107 bp
fragment from 
H indlll digest
89 and 40 bp 
fragments from 
Narl digest
Figure 5 -  Example of Agarose Gels from Mismatch Repair Analyses. After 
transfection of mismatched plasmid, DNA was isolated and PCR amplified from each 
NIH 3T3 colony as described (Materials and Methods). A 25 bp DNA ladder was run in 
the initial lane of each gel with the darkest band representing 125 bp. (A) Check of PCR 
amplification reaction. Lane 1: Negative control with no DNA added, Lanes 2- 10: 
amplification of 129 base pair fragment. (B) Hindlll digestion of aliquots from each 
amplification. Lanes 2-6, 8-10: 107 base pair Hindlll digested fragment. Lane 7: 
sample is not digested with Hindlll and therefore represents transfected p220.pbc-H/B 
vector. (C) Narl digestion of aliquots from each +H/B sample. Lane 2: partial digest 
indicates sample is a mixture of wild-type and transformed sequences. Lanes 3-6, 8-10: 
complete digestion indicates wild-type sequences only.
Purification Kit as described by the manufacturer (Qiagen, Inc.), eluted in 20 |al of dt^O  
and then digested with 25 units of Hindlll (New England Biolabs) overnight at 37°C.
The digested samples were electrophoresed on a 4% NuSieve 3:1 gel (FMC BioProducts) 
and analyzed (see Figure 5B). Any samples which were not digested by the Hindlll 
(p220.pbc-H/B instead of +H/B heteroduplex) were eliminated. A 20 p.1 aliquot of each 
correctly amplified product was then digested with 5 units o f Turbo Nae I  restriction 
enzyme (Santa Cruz Biotechnology) for codon 12 analysis or 2.5 units of Turbo Nar I  
(Santa Cruz Biotechnology) for codon 10 analysis in the supplied buffers for 4 hr. The 
digestion products were electrophoresed on a 4% NuSieve 3:1 gel (FMC BioProducts) 
and analyzed (see Figure 5C). Only PCR amplified DNA containing wild-type human H- 
ras at the relevant codon is cleaved by these restriction enzymes. If the PCR amplified 
DNA was not completely cleaved, a 20 (il aliquot was treated with 10 units each of the 
enzymes SAP (USB Corporation) and Exol (USB Corporation) and incubated for 15 min 
at 37°C followed by heat inactivation of the enzymes at 80°C for 15 min. The DNA was 
then cycle-sequenced as described by the manufacturer (Amersham Pharmacia Biotech), 
run on a 12% polyacrylamide gel (19:1 acrylamide to bisacrylamide) and exposed 
overnight to film (Eastman Kodak Corporation) to determine the exact mutation.
F. Preparation o f  Oligonucleotides fo r Gel-Shift Assays
For these experiments, 32-mer oligonucleotides were derived from the H-ras 
sequence surrounding codon 10 and 12. These have the sequence of 5’-
FGGTGGTGGTGGXCGCCGYCGGTGTGGGCAAGA-3’ or 5’- 
GGTGGGCGCCGYCGGTGTGGGCAAGAGTGCGC-3’, in which X represents the 
middle base of YL-ras codon 10 and Y represents the middle base of H-ras codon 12. 
Wild-type oligonucleotides were 5’end labeled using [y-32P] ATP (3,000 Ci/mmol) (NEN 
Life Science Products, Inc.) and T4 phosphonucleotide kinase (Promega Corporation) at 
a DNA concentration of 1 pmol/|il for 1 hr as described by the manufacturer. The 
phosphorylation reaction was quenched by adding 1 jj.1 of 0.5 M EDTA (pH 8.0) and 89 
jil of Tris-EDTA (pH 7.5). The oligonucleotides were then purified from non­
incorporated nucleotides by filtration through a sephadex G-25 spin column equilibrated 
in Tris-EDTA, pH 7.5 at 300 x g for 3 min. The 5’ [32P]-labeled wild-type single­
stranded oligonucleotides were annealed to the complementary oligonucleotides (wild- 
type or mismatch containing) at a 1:3 molar ratio of labeled wild-type oligonucleotide to 
unlabeled complementary oligonucleotide at a final DNA concentration o f 0.3 pmol/|iil 
and a final volume of 100 fil in a buffer consisting of ImM Tris-HCl (pH 8.0), 1 mM 
MgCh. The solution was heated to 95°C for 5 minutes and then allowed to cool to room 
temperature over a 2-hr time period prior to rapid cooling to 4°C. Unlabeled wild-type 
competitor oligonucleotide was prepared similarly. No detectable labeled single-stranded 
oligonucleotide was found when these substrates were examined by native 
polyacrylamide electrophoresis. The specific activity of each double-stranded 
oligonucleotide was determined by liquid scintillation counting in 5 ml o f Sigma-Fluor 
liquid scintillation cocktail (Sigma Chemical Company).
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G. Gel-Shift Assays
HeLa nuclear extracts for the nuclear protein-DNA binding reactions were 
purchased from Promega Corporation and were resuspended in a buffer consisting of 20 
mM Hepes (pH 7.9), 20% glycerol, 0.1 M KC1, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM 
DTT. NIH 3T3 nuclear extracts were purchased from Santa Cruz Biotechnology and 
were resuspended in a buffer consisting o f 20 mM Hepes (pH 7.9), 20% glycerol, 0.1 M 
KC1, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT (232). For each reaction involving 
HeLa nuclear extracts, 10 |ig of the protein was first placed in a binding buffer containing 
4% glycerol, 1 mM MgCb, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris- 
HC1 (pH 7.5), and 0.05 |J.g/ml poly(dI-dC)-poly(dI-dC) and pre-incubated for 40 min at 
room temperature. For reactions involving NIH 3T3 nuclear extracts, 10 ng of the 
protein was pre-incubated for 40 min at 4°C in a binding buffer consisting of 10% 
glycerol, 25 mM Hepes-KOH (pH 8.0), 0.5 mM EDTA, 0.1 mM ZnCh, 0.5 mM DTT,
0.05 |Xg/ml poly(dI-dC)-poly(dI-dC). Nuclear protein-DNA binding reactions were then 
carried out at 4°C in a total volume of 10 |il using 35 fmol of radioactively labeled 
oligonucleotide and 0.9 pmol of unlabeled double-stranded wild-type competitor 
(approximately a 1:25 molar ratio). The mismatched oligonucleotide substrate and 
competitor wild-type oligonucleotide were added simultaneously and the reactions were 
incubated for a further 30 min at 4°C to allow the proteins to interact with the DNA.
Following nuclear protein-DNA binding, 1 |il of a non-denaturing loading buffer 
(250 mM Tris-HCl (pH 7.5), 0.2% bromphenol blue, 40% glycerol) was added and the
samples were loaded onto a 6% polyacrylamide non-denaturing gel (39:1 acrylamide to 
bisacrylamide). Electrophoresis was carried out at 4°C at 100 Volts (10 Volts/cm) in 
TBE. Gels were then dried and exposed to Biomax film (Eastman Kodak Corporation). 
Autoradiographs were scanned and analyzed using NIH Image Software. In experiments 
to assess efficiency of binding to different radioactive substrates, equal amounts of 
radioactivity were used as determined by liquid scintillation counting. Competition 
assays using unlabeled mismatched oligonucleotides as competitors were conducted 
exactly as above except for substitution of unlabeled mismatched oligonucleotide for the 
unlabeled wild-type oligonucleotide. For antibody binding assays, 1 (Xg of monoclonal 
anti-hMSH6 antibody (Santa Cruz Biotechnology, Inc.) was allowed to incubate with the 
nuclear extracts for 20 minutes prior to addition o f the DNA mixture. For ATP inhibition 
assays, 1 mM ATP was added to the binding buffer prior to addition of nuclear extract 
and DNA.
H. Preparation o f  Oligonucleotides fo r  UV Cross-linking, Immunoprecipitation and 
Western Blotting Assays
A 32-mer oligonucleotide having the sequence of 5’- 
GGTGGGCGCCGGCGGTGTGGGCAAGAGTGCGC-3’ (Operon Technologies, Inc.) 
was used for these assays with the bolded G specifying the location of the mismatch. 
Wild-type oligonucleotides were 5’ end-labeled using [y-32P] ATP (6,000 Ci/mmol)
(NEN Life Science Products, Inc.) and T4 polynucleotide kinase for 1 hr at 37°C as
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described by the manufacturer (Promega Corporation). The phosphorylation reaction 
was quenched by adding 1 jj.1 of 0.5 MEDTA (pH 8.0) and 89 (il of Tris-EDTA (pH 7.5), 
and the oligonucleotides were then purified from unincorporated nucleotides using a 
Sephadex G-25 spin column equilibrated in Tris-EDTA (pH 7.5) at 300 x g for 3 min.
'i'y
Aliquots from the same batch of 5’ [ P] -labeled wild-type oligonucleotide were 
annealed to complementary oligonucleotides containing a C (homoduplex), T 
(heteroduplex, G:T) or A (heteroduplex, G:A) opposite the bolded G, thereby producing 
double-stranded oligonucleotides with similar specific radioactivities. The annealing was
' i ' j
performed at a 1:3 molar ratio of 5’ [ P] -labeled to unlabeled oligonucleotide at a final 
DNA concentration of 0.3 pmol/fil and a final volume of 100 |L t l  in 10 mM Tris-HCl (pH 
8.0), 10 mM MgCb. The solution was heated to 95°C for 5 min and then allowed to cool 
to 20°C over 2 hr followed by rapid cooling to 4°C. Unlabeled wild-type competitor 
oligonucleotides were prepared similarly. No detectable labeled single-stranded 
oligonucleotide was found when these substrates were examined by native 
polyacrylamide electrophoresis.
I. UV Cross-linking and Immunoprecipitation
HeLa nuclear protein-DNA binding reactions for UV cross-linking and 
immunoprecipitation experiments were carried out in a binding buffer containing 4% 
glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris-HCl 
(pH 7.5), 0.05 (Xg/ml poly (dl-dC)- poly (dl-dC) and 165 |Lig of nuclear extract in 10
aliquots with a combined total volume of 200 |0,1. The nuclear extract was added to the 
binding buffer and allowed to incubate for 30 min at room temperature. A DNA mixture 
containing 1.05 pmol of 5’ [32P] -labeled double-stranded oligonucleotide (either 
heteroduplex or homoduplex) and 27 pmol of unlabeled double-stranded homoduplex 
competitor (an approximately 1:25 molar ratio of 5’ [32P] -labeled to unlabeled 
oligonucleotide) was then added and the reactions were placed on ice for 40 min to allow 
binding of nuclear proteins to the oligonucleotides. All subsequent steps were performed 
at 0°C-4°C. Bound proteins were UV cross-linked to the DNA using a 5 min exposure on 
ice at 254 nm in a UV Stratalinker (Stratagene) at approximately 5 cm from the UV 
source. 3 |j.g of the indicated antibody was added and the reactions were placed on a 
rolling mixer overnight to allow coupling of the antibodies to their antigen. 40 |il of a 
Protein-G Sepharose 4 Fast Flow slurry (Amersham Pharmacia Biotech) was next added 
to precipitate the immunoglobulins and the reactions were rotated for a further 3 hr at 
4°C. The immunoprecipitates were then recovered by centrifugation (200 x g, 1 min), 
washed 2 times with a buffer consisting of 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 
0.1% Triton X-100, 0.025% NaN3 and 0.1% BSA, washed 1 time with a buffer consisting 
of 10 mM Tris-HCl (pH 8.0), 150 mM NaCl and 0.025 % NaN3 and then washed 1 time 
with a buffer consisting of 50 mM Tris-HCl (pH 6.8). Between each wash the samples 
were centrifuged at 200 X g for 1 min to pellet the beads and the supematent was 
aspirated with a fine-tipped Pasteur pipette. After the final wash, approximately 10 |ii of 
the buffer was left in the microcentrifuge tubes and an equal volume of 2X SDS sample 
buffer (Tris-HCL/SDS (pH 6.8), 4% SDS, 20% glycerol, 2% 2-mercaptoethanol, 10
(ig/ml bromphenol blue) was added. The samples were heated for 5 min at 100°C with 
the caps open, placed on ice and loaded onto a 7.5% discontinuous SDS polyacrylamide 
gel (stacking gel 30% acrylamide/0.8% bisacrylamide, 4% Tris-HCl/SDS (pH 6.8); 
separating gel 30% acrylamide/0.8% bisacrylamide, 4% Tris-HCl/SDS (pH 8.8)). 
Following electrophoresis at 10 mA for 2 hr, gels were dried and exposed to Biomax film 
(Eastman Kodak Corporation) to detect precipitated labeled oligonucleotide. Assays 
involving ATP were performed as above except that ATP (Sigma Chemical Company) at
0.1 mM was added immediately prior to the UV cross-linking step.
J. Western Blotting
Nuclear protein was bound to the DNA substrates, UV cross-linked, 
immunoprecipitated and electrophoresed as above. The resulting gel was then transferred 
overnight at 10 mA onto a pre-wetted nitrocellulose membrane (Schleicher and Schuell, 
Inc.) using a Trans-Blot apparatus (Bio-Rad Laboratories) in a transfer buffer consisting 
of 2.5 mM Tris, 19.2 mM glycine. For Western blotting, membranes were placed in 
blocking buffer (5% non-fat milk in Tris-buffered saline (pH 7.6), 0.1% Tween 20 (TBS- 
T) for 1 hr with agitation. The membrane was then washed by rinsing briefly twice in 
TBS-T, placing the membrane in fresh TBS-T with agitation for 15 min and then placing 
it again in fresh TBS-T twice for 5 min with agitation. The membrane was next 
incubated with primary antibody in TBS-T with agitation for 1 hr. The dilution of 
antibody to TBS-T was 1:200 for hMSH2, hMLHl and hPMS2, and 1:2000 for hMSH6
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and hPMS 1. Excess primary antibody was washed from the membrane by rinsing briefly 
twice in TBS-T, placing the membrane in fresh TBS-T with agitation for 15 min and then 
placing it again in fresh TBS-T twice for 5 min with agitation. The membrane was then 
incubated in TBS-T with secondary antibody against the specific primary antibody used. 
For hMSH2 a horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin 
antibody (Amersham Pharmacia Biotech) was used at a dilution of 1:1000. For hMSH6 
an HRP conjugated anti-goat immunoglobulin antibody (Santa Cruz Biotechnology) was 
used at a dilution of 1:1000. For hM LHl, hPMS2 and hPMSl a biotinylated anti-rabbit 
immunoglobulin antibody (Sigma Chemical Company) was used at a dilution of 1:1000. 
Excess secondary antibody was washed from the membrane again by rinsing briefly 
twice in TBS-T, placing the membrane in fresh TBS-T with agitation for 15 min and then 
placing it in fresh TBS-T twice for 5 min with agitation. For hM LHl, hPMS2 and 
hPMS 1 (and when biotinylated molecular weight markers were used, see below) the 
membrane was then incubated with streptavidin-HRP (Amersham Pharmacia Biotech) for 
1 hr in TBS-T with agitation at a dilution of 1:1500 to bind the HRP enzyme to the biotin 
via streptavidin. Bound antibodies were detected by ECL detection of the HRP enzyme 
as described by the manufacturer (Amersham Pharmacia Biotech). Between each probe 
the membrane was stripped of bound antibodies by a 30 min incubation at 55°C in 100 
mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.7).
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K. Molecular Weight Determination
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For UV cross-linking and immunoprecipitation experiments high-range molecular 
weight markers (Bio-Rad Laboratories) were run on each gel. 5 (il of the protein mix was 
added to 5 jil o f 2X SDS sample loading buffer (Tris-HCL/SDS (pH 6.8), 4% SDS, 20% 
glycerol, 2% 2-mercaptoethanol, 10 |ig/ml bromphenol blue) and heated for 5 min at 
100°C. The microcentrifuge tubes were then placed on ice and the samples loaded on the 
gels. After electophoresis the gels were stained with the Zoion Fast Stain Coomasie blue 
staining kit as described by the manufacturer (Zoion Biotech) to visualize the molecular 
weight markers. For Western blotting experiments, biotin-conjugated high range 
molecular weight standards (Bio-Rad Laboratories) were used. An incubation with 
streptavidin-horseradish peroxidase (Amersham Pharmacia Biotech) was included at a 
1:1500 dilution to bind the HRP enzyme to the biotinylated proteins via streptavidin and 
ECL detection was performed as described by the manufacturer (Amersham Pharmacia 
Biotech) to visualize the molecular weight markers.
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III. Results
A. In Vivo Mismatch Repair Rates
To determine if there is a deficiency in mismatch repair at the H-ras hotspot of 
mutation, repair rates were determined in vivo in non-synchronous NIH 3T3 cells for 
each of the specific mismatches when located at the middle nucleotide of codon 10 of H- 
ras. Previously, in vivo rates of repair for specific mismatches at the middle nucleotide 
position of the W-ras codon 12 hotspot of mutation were determined in non-synchronized 
NIH 3T3 cells (227) (summary of results shown in Figure 6 for comparison). Codon 10 
has the same primary sequence as codon 12 (GGC) with the middle nucleotide of each 
separated by only 6 basepairs. However, codon 10 does not appear to be a hotspot of 
mutation, as there have not been mutations at this sequence found in any in vitro 
activation assay or in vivo in naturally occurring human tumors (203 - 205).
Analysis of in vivo mismatch repair by individual cells was performed by 
transfecting with mismatch-containing plasmid, selecting for the growth of carbenicillin- 
resistant E. coli or hygromycin-resistant NIH 3T3 colonies, isolating the DNA and PCR 
amplifying a 129 base pair segment from the plasmid containing H-ras codon 10. The 
samples were then analyzed by restriction digest with the Narl enzyme (Promega 
Corporation) to determine the sequence at codon 10. Any samples not completely 
digested by Narl were cycle-sequenced to determine the sequence at codon 10 (227,
228). Figure 5 shows an example of the gels resulting from this process.
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Figure 6 - Comparison of Mismatch Repair Rates for H-ras Codon 10 and Codon
12. Repair rates for codon 12 in non-synchronized cells were reported in Arcangeli et. al. 
(227) and are shown here for comparison (correct repair at codon 12: G:A ->  35%, A:C 
->  58%, T:C ->80%, G:T ->100%), correct repair at codon 10 G:A ->  69%, A:C ->  
94%, T:C ->96% , G:T ->  96%. Repair percentages include all mismatches repaired 
correctly to G:C, but not mismatches which are replicated before repair and thus are 
found as mixtures in the resulting colony.
A number of controls were performed to assess the quality and purity of our 
mismatched plasmid preparations and repair results. Each mismatch plasmid was 
prepared at least twice to verify reproducibility o f results. Further controls in which 
mismatch-containing plasmid was transformed into mismatch repair deficient bacteria 
(NR9161, mut L') yielded only unrepaired mixtures in the resultant colonies (227). Also, 
control transfections of plasmid containing either the wild-type or mutated sequence were 
included with each experiment to ensure that analysis of the sequence at codon 12 yielded 
the expected results after PCR amplification. Finally, all PCR amplified samples were 
digested with Hindlll (New England Biolabs) to ensure that the heteroduplex plasmid 
(+Hindlll/Bst9Sl, see Materials and Methods) was used for the transfection and not the 
undigested vector (p220.pbc-H/B) (see Figure 5).
Each mismatch preparation was also transformed into E. coli as we have 
previously demonstrated that E. coli is not transformed by gapped plasmid (minus the 
mismatch oligonucleotide) and that codon 12 of W-ras is not a hotspot of mutation in 
bacteria (227). As seen in Table 2, codon 10 of W-ras is also not a hotspot of mutation in 
E. coli. G:A mismatches are the least efficiently repaired, as at the codon 12 location and 
as observed by other investigators (176, 178, 233 - 235). In E. coli, all mismatches that 
are unrepaired result in a mixture of G:C and T:A or A:T, depending on the mismatch, 
rather than an incorrectly repaired mismatch (only T:A or only A:T). These mixtures 
most probably result from replication o f the mismatched plasmid in the original 
transformed cell prior to replication and thus the percent of mixtures reflects the 
efficiency of repair.
Table 2 - Repair of mismatches at codon 10 of 
H-ras in E. coif.
Correctly Repaired 
Mismatch - >  G:C 
(Total Assayed)
Incorrectly Repaired 
Mismatch - >  T:A or A:T 
(Total Assayed)
Unrepaired 
Mismatch - >  G:C and 
T:A or A:T 
(Total Assayed)
Mismatch
G:A 94% 0 % 6%
(31/33) (0/33) (2/33)
A:C 1 0 0 % 0 % 0 %
(41/41) (0/41) (0/41)
T:C 98% 0 % 2%
(59/60) (0/60) (1/60)
G:T 1 0 0 % 0 % 0 %
(51/51) (0/51) (0/51)
"A portion o f  each mismatch preparation used in NIH 3T3
studies was used to transform mismatch proficient E. coli
as a control (see Results).
Table 3. Repair of mismatches at codon 10 of 
H-ras in non-synchronized NIH 3T3 cellsa.
Correctly Repaired 
Mismatch - >  G:C 
(Total Assayed)
Incorrectly Repaired 
Mismatch ->  T:A or A:T 
(Total Assayed)
Unrepaired 
Mismatch - >  G:C and 
T:A or A:T 
(Total Assayed)
Mismatch
G:A 69% 0 % 3 1 %
(25/36) (0/36) (11/36)
A:C 94% 0 % 6%
(47/50) (0/50) (3/50)
T:C 96% 0 % 4%
(47/49) (0/49) (2/49)
G:T 96% 0% 4%
_________________ (49/51)_______________ (0/51)_________________ (2/51)
Codon 10 is not a hotspot o f  mutation in H-ras.
The E. coli results also confirm that our mismatched plasmid correctly directs 
repair to the DNA strand containing the mismatched 30-mer oligonucleotide. The 
methodology used to prepare the mismatched plasmid does not facilitate hemimethylation 
d(GATC)-directed mismatch repair by E. coli. However, the procedure does produce a 
pre-ligation total o f four nicks on the DNA strand containing the incorrect mismatched 
nucleotide (each end of the 1.8 kb double-stranded fragment plus each end of the single­
stranded 30-mer mismatched oligonucleotide) versus two ‘nicks’ on the opposite DNA 
strand (each end of the double-stranded 1.8 kb fragment only) during preparation of 
mismatched DNA (Figure 4). In vitro ligation is highly unlikely to be 100% efficient and 
therefore, this protocol was determined to be appropriate for biasing the selection for 
plasmids containing unligated ‘nicks’ on the strand containing the incorrect nucleotide. 
The lack o f E. coli samples where the mismatch plasmid is incorrectly repaired confirms 
that this procedure correctly directs repair to the strand containing the mismatched 
oligonucleotide.
As seen in Table 3 and Figure 5, in NIH 3T3 cells there is a significant 
improvement in correct mismatch repair rates for codon 10 as compared to codon 12 for 
G:A, A:C and T:C mismatches, while the repair rate for G:T remains at a high level. 
These results clearly demonstrate that repair of mismatched nucleotides is more efficient 
at codon 10 than at codon 12 in NIH 3T3 cells, indicating that codon 12 is a hotspot of 
mutation, at least in part, due to inefficiencies in accomplishing mismatch repair. 
Furthermore, as both codon 10 and codon 12 have a primary sequence of GGC, the only 
difference between the mismatches at codon 10 and codon 12 is the surrounding
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sequence context. Therefore, these results demonstrate for the first time that deficiencies 
in mismatch repair can affect mutation rates at a hotspot of mutation and that sequence 
context can affect mismatch repair efficiency.
B. In Vitro Nuclear Protein Binding to Mismatches at the Codon 12 Hotspot and at 
Codon 10
Gel-shift nuclear protein-DNA binding assays were used to assess potential 
differences in mismatch-specific binding to the different mismatches at the codon 12 
hotspot and at codon 10. 32-mer double stranded oligonucleotides were constructed 
based on the human H-ras genetic sequence with a specific mismatch located at the 
middle nucleotide of either codon 12 or codon 10. To ensure that the proximate location 
of codon 10 or codon 12 to the 3’ or 5’ end of the oligonucleotide was not affecting 
binding, an additional set o f oligonucleotides were used in which the codon 12 position 
was identical in relation to the 3’ and 5’ end as the position o f codon 10 in the first set of 
oligonucleotides, with similar results (Materials and Methods). All experiments were 
performed with both NIH 3T3 nuclear extracts and with mismatch repair proficient 
nuclear extracts from the human cell line HeLa (176)(Figure 7 A and 7B). In each 
reaction an excess of unlabelled homoduplex competitor was added to control for non- 
mismatch-specific interactions as well as an excess of poly(dI-dC)-poly(dI-dC) to control 
for non-specific DNA binding interactions. Two mismatch-specific bands were observed 
on non-denaturing polyacrylamide gels when using HeLa nuclear extracts and one band 
was observed when using NIH 3T3 nuclear extracts. Densitometry measurements were
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Figure 7 - Relative Amounts of Nuclear Protein Binding to Specific Mismatches at 
Codon 10 or Codon 12 of H -ras. Gel-shift assays were performed using equal amounts 
of radioactivity for each mismatch. Arrows indicate mismatch specific bands. (A)
HeLa nuclear extract binding to mismatches at codon 10 or codon 12. (B) NIH 3T3 
nuclear extract binding to codon 12 mismatches. (C) Comparison of the relative 
amounts of HeLa mismatch specific nuclear extract binding at codon 10 and codon 12. 
(D) Comparison of the relative amounts of NIH 3T3 mismatch specific nuclear extract 
binding at codon 12. Autoradiographs were analyzed using NIH Image software. 
Relative amounts of each mismatch were compared with the amount bound to the G:T 
containing oligonucleotide which was arbitrarily set at 100%. Averages were 
determined from three separate experiments.
performed to determine the relative amounts of mismatch-specific protein binding (both 
bands for HeLa nuclear extracts and the one band for NIH 3T3 nuclear extracts) after 
incubation of the nuclear extracts with each mismatch tested (Figure 7C and 7D). As 
shown in Figure 7D, the relative amounts o f mismatch-specific binding correlates closely 
to our observed in vivo mismatch repair rates for the H-ms codon 12 site. Additionally, 
as shown in Figures 7A and 7C, there is virtually no mismatch-specific binding to the 
G:A mismatch located at codon 12, while at codon 10 there are observable levels of 
binding o f just the slower migrating band to this same mismatch. This demonstrates a 
sequence context effect in binding by the mismatch-specific factors, and is especially 
intriguing in light of the low levels of repair of G:A mismatches at the codon 12 position 
and correspondingly higher levels of repair at codon 10.
To determine the identity of the binding factor we included monoclonal 
antibodies specific for the known DNA binding domain of hMSH6, a component of the 
hM utSa heterodimer. As seen in Figure 8A, incubation of anti-hMSH6 antibody with 
HeLa nuclear extract before the addition of mismatch DNA results in a marked decrease 
in binding by the slower migrating mismatch-specific band to G:T mismatches at codon 
10. In additional experiments, ATP was added to the nuclear protein-mismatch DNA 
incubations, as ATP has been demonstrated to inhibit binding of the hM utSa complex to 
mismatched DNA (108, 120 - 122). As shown in Figure 8B, 1 mM ATP completely 
inhibits all mismatch-specific protein binding to the codon 10 G:T mismatched 
oligonucleotide. This inhibition of binding was also observed for all other specific 
mismatches at both codons 10 and 12 with either NIH 3T3 or HeLa nuclear extracts
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Figure 8 - Effect of anti-hMSH6 Antibody and ATP on Mismatch Specific Binding.
Gel-shift assays were performed as described in Materials and Methods using HeLa 
nuclear extracts. (A) 1 (ig of anti-hMSH6 antibody (Santa Cruz Biotechnology, Inc.) was 
added to nuclear extract prior to addition of oligonucleotides as indicated (+ lane), 
resulting in a disruption of binding. (B) 1 mM ATP was added to the binding buffer 
prior to addition of nuclear extract and oligonucleotides as indicated (+ lane), resulting in 
disruption of all mismatch specific binding.
Competitor -  12GT 10GT -  12GT 10GT -  12GT 10GT -  -  12AC 12GT 10GT
Substrate -  12GT 10GT 12TC -  12AC
Figure 9 -  Competition Assays. Gel-shift assays were performed as described in 
Materials and Methods with NIH 3T3 nuclear extracts using an excess of unlabeled 
mismatch-containing oligonucleotide as the competitor. All shown mismatches are able 
to compete away the mismatch specific band demonstrating that the same binding activity 
is responsible for the binding, regardless of which mismatch is used as the 5’ [32P] - 
labeled substrate.
(results not shown). Competition assays using an excess o f non-radioactively labeled 
mismatched oligonucleotide demonstrated inhibition of binding between each 
mismatched competitor oligonucleotide when using either NIH 3T3 or HeLa nuclear 
extracts (see example in Figure 9). This demonstrates that the same binding factor was 
responsible for the mismatch-specific binding to each of the mismatches. Taken together 
the above results indicate that the mismatch-specific binding factor observed for each 
mismatch in NIH 3T3 cells and the slower migrating band we observe with HeLa nuclear 
extracts is the hM utSa complex. We cannot conclusively identity the faster migrating 
band observed with HeLa nuclear extracts, although based on its release from the 
oligonucleotide substrate upon addition of ATP, it is likely to represent a mismatch repair 
protein or protein complex. One possibility is that this band is the hMutS(3 heterodimer 
bound to mismatched DNA.
C. In Vitro Mismatch Repair Protein Interactions
1. hMSH6, hMSH2, hMLHl, and either hPMS2 or hPMSl form  a mismatch repair 
protein complex that interacts specifically with heteroduplex DNA
Immunoprecipitation experiments followed by Western blotting were performed 
to determine the exact proteins bound to the mismatched oligonucleotides and to 
determine the nature of the interactions between the mismatch repair proteins and the 
DNA. HeLa nuclear extracts, which are mismatch repair proficient (176), were incubated
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with a mixture of 5’ [32P] -labeled DNA substrate (either homoduplex or heteroduplex) 
mixed with unlabeled homoduplex competitor to control for non-mismatch-specific 
interactions and poly(dI-dC)-poly(dI-dC) (not a mismatch) to control for non-specific 
DNA binding interactions. Use of whole nuclear extracts instead of purified proteins 
enabled the search for novel protein interactions. The sequence o f the oligonucleotide 
substrate used was based on that of W-ras with a G:T mismatch located at the middle 
nucleotide of codon 10. Mutations at this location have not been found in any human 
tumors (204, 205) and in the previous experiments a high rate of correct repair of G:T 
mismatches at codon 10 was demonstrated in mammalian cells (236), lending further 
support to the mismatch repair proficiency of this system.
Nuclear extracts were incubated with the DNA, the bound proteins were UV 
cross-linked to the oligonucleotides (see below) and immunoprecipitation was performed. 
The samples were then run on a denaturing polyacrylamide gel, transferred to a 
nitrocellulose membrane and Western blotting was performed on the resulting membrane. 
In Figure 10, antibody against hMSH6 was used for immunoprecipitation and the 
resulting membrane was sequentially probed for hMSH6, hMSH2, hM LHl, hPMS2, and 
hPM Sl, with stripping of bound antibody between each probe. The bands seen in Figure 
10B result from chemiluminescent detection of bound antibody. As shown in the hMSH6 
Western blot, antibody against hMSH6 is able to immunoprecipitate itself, demonstrating 
the efficiency of the immunoprecipitation and Western blotting protocols. Antibody 
against hMSH6 is also capable of co-immunoprecipitating hMSH2, hM LHl, hPMS2 and 
hPM Sl, indicating the existence of a mismatch repair complex or complexes consisting
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Figure 10 -  hMSH6 Immunoprecipitation and Subsequent Autoradiogram and 
Western Blots. (A) HeLa nuclear extracts were incubated with 5’ [32P] -labeled 
homoduplex DNA (GC, Lanel) or heteroduplex DNA (GT, Lane 2) in the absence of 
ATP. Bound proteins were UV cross-linked to the DNA, and immunoprecipitated with 
antibody against hMSH6. An autoradiogram of the SDS-polyacrylamide gel is shown. 
Bands represent proteins bound to 5’ [32P] -labeled oligonucleotides. Arrows indicate 
mismatch specific binding activities (hMSH6, and proteins that run to the approximate 
positions of 115 kDa (A), 95 kDa (B) and 50 kDa (C)). (B) HeLa nuclear extracts were 
incubated with DNA as above in either the absence (Lanes 1 and 2) or presence (Lanes 3) 
of 0.1 mM ATP. After hMSH6 immunoprecipitation and SDS-poylacrylamide 
electrophoresis, parallel lanes from the same gel as in (A) were transferred to a 
nitrocellulose membrane. Western blotting was performed with the indicated antibody 
probes (Western ab) with stripping of bound antibody between probes. Bands result from 
chemiluminescent detection of bound antibody. The large dark band at the bottom of all 
blots results from detection of immunoglobulins used in immunoprecipitation.
of at least these proteins. These protein-protein interactions occur in the absence of 
additional ATP and occur to an approximately equal extent in the presence of either 
homoduplex or heteroduplex DNA.
In these same experiments, autoradiography was performed on parallel lanes of 
the same gel to determine which of the proteins identified above were also capable of 
becoming UV cross-linked to the 5 ’ [32P] -labeled DNA (and not the unlabelled 
homoduplex competitor) and thus physically interacts with the DNA. As seen in Figure 
10A four bands are observed where proteins bind specifically to 5’ [32P] -labeled 
heteroduplex DNA (Lane 2) and not to the similar 5’ [32P] -labeled homoduplex DNA 
(Lane 1). By comparing the bands seen in Figure 10A to those identified in the Western 
blots in Figure 10B it can be seen that the highest molecular weight band runs to 
approximately the same position on the gel as hMSH6. This band has been identified as 
hMSH6 bound to the mismatched DNA as (1) the size of this band correlates with the 
predicted molecular weight of 160 kDa for hMSH6, (2) binding to the mismatched DNA 
is disrupted upon addition of ATP (see Figure 16) and (3) a number of previous studies 
have indicated the mismatch-specific DNA binding activity o f hMSH6 when in the 
hM utSa complex (117, 120). Therefore, the predominant mismatch-specific DNA 
binding activity observed within nuclear extracts in these studies is hMSH6. This 
binding to the DNA occurs only with the mismatched oligonucleotide and is not seen
32when the 5’ [ P] -labeled homoduplex substrate is used. We also observe mismatch- 
specific DNA binding proteins that run to the approximate positions of 115 kDa (A), 95 
kDa (B) and 50 kDa (C) (indicated with arrows). To be observed in Figure 10A, these
78
proteins must be UV cross-linked to the mismatched oligonucleotide (approximately 10 
kDa). Therefore these bands represent proteins of approximately 102 kDa (A) 83 kDa 
(B) and 37 kDa (C). It is possible that the A, B and/or C proteins are components of the 
complexes involving hMSH2, hMSH6, hMLHl and hPMS2/hPMSl. Alternatively, as 
HeLa nuclear extracts are mismatch repair proficient, these bands may represent proteins 
that become bound to mismatched DNA in subsequent steps in the repair process.
To confirm that the mismatch repair proteins exist as a complex within HeLa 
nuclear extracts, the above experiments were repeated using antibody against hMLHl for 
the immunoprecipitation (Figure 11). Western blotting was then performed with the 
membrane probed with antibodies against hMSH6, hMSH2, hM LHl, hPMS2, and 
hPM Sl. Again, the bands seen in the Western blots in Figure 11 result from 
chemiluminescent detection of bound antibody. As seen in Lanes 1 and 2 of Figure 11, 
these experiments demonstrate an interaction between hMLHl and hMSH6, hMSH2, 
hPMS2, and hPMSl in the absence of added ATP, confirming the results in Figure 10B. 
In the absence of ATP, antibody against hMLHl was able to co-immunoprecipitate each 
of the other proteins in the presence of both homoduplex and heteroduplex DNA. Similar 
co-immunoprecipitation o f all the mismatch repair proteins in the absence of additional 
ATP was observed when antibody against hMSH2 was used (Figure 12, Lanes 1 and 3). 
Interestingly, when antibody against hPMS2 is used for immunoprecipitation hPMS 1 
does not co-immunoprecipitate (Figure 13). As well, antibody against hPMSl does not 
co-immunoprecipitate hPMS2. As co-precipitation of both hPMS2 and hPMSl is 
observed when antibodies against hMSH6 (Figure 10), hMLHl (Figure 11) or hMSH2
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Figure 11 - hM LHl Immunoprecipitation and Subsequent Western Blotting. HeLa 
nuclear extracts were incubated with homoduplex (GC, Lane 1) or heteroduplex (GT, 
Lanes 2 and 3) DNA in the absence or presence of 0.1 M ATP as indicated. Bound 
proteins were UV cross-linked to the DNA and immunoprecipitation was performed with 
antibody against hM LH l. Following SDS-polyacrylamide electrophoresis and transfer to 
nitrocellulose, Western blotting was performed with the indicated antibody probes 
(Western ab), with stripping of bound antibody between probes. Chemiluminescence 
was used for detection with sequential stripping of the membrane between probes. Bands 
result from chemiluminescent detection of bound antibody and do not represent protein 
bound to 5 ’ [32P] -labeled oligonucleotide.
I.
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Figure 12 -  hMSH2 Immunoprecipitation and Subsequent Western Blotting. HeLa 
nuclear extracts were incubated with homoduplex (GC, Lanes 1 and 2) or heteroduplex 
(GT, Lanes 3 and 4) DNA in the absence or presence of 0.1 M ATP as indicated. Bound 
proteins were UV cross-linked to the DNA and immunoprecipitation was performed with 
antibody against hMSH2. Following SDS-polyacrylamide electrophoresis and transfer to 
nitrocellulose, Western blotting was performed with the indicated antibody probes, with 
stripping of bound antibody between probes (Western ab). Chemiluminescence was used 
for detection with sequential stripping of the membrane between probes. Bands result 
from chemiluminescent detection of bound antibody and do not represent protein bound 
to 5’ [32P] -labeled oligonucleotide.
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Figure 13 - hPM Sl and hPMS2 Do Not Co-immunoprecipitate Each Other. HeLa 
nuclear extracts were incubated with heteroduplex DNA in the absence of ATP and 
immunoprecipitation was performed using antibody against hPMS 1 (IP antibody in Lanes 
1 and 4) or hPMS2 (IP antibody in Lanes 2 and 3). After SDS-polyacrylamide 
electrophoresis and transfer to nitrocellulose, Western blotting was performed with the 
indicated antibody probes (Western ab). Chemiluminescence was used for detection with 
sequential stripping of the membrane between probes.
(Figure 12) are used for the initial immunoprecipitation, it can be concluded that either 
hPMS2 or hPMS 1 exists in the mismatch repair complex but not both together.
Therefore two mismatch repair protein complexes exist; one consisting of hMSH6, 
hMSH2, hMLHl and hPMS2 and the other consisting o f hMSH6, hMSH2, hMLHl and 
hPM Sl.
The ability o f the mismatch repair proteins to interact in solution in the absence of 
the 32-mer oligonucleotides was also examined. In Figure 14, the nuclear extracts were 
incubated in the binding buffer without the addition of the 5’ [32P] -labeled 
oligonucleotides. Immunoprecipitation was performed with antibodies against both 
hMSH2 and hMLHl and the membrane from the resulting denaturing polyacrylamide gel 
was probed with antibodies against the various mismatch repair proteins. As can be 
observed, antibodies against hMSH2 and hMLHl are capable o f co-immunoprecipitating 
hMSH6, hPMS2 and hPMS 1, demonstrating that the mismatch repair proteins exist as a 
complex in the absence of the 32-mer DNA substrates. However, as it was necessary to 
include poly (dl-dC)-poly (dl-dC) to bind non-specific DNA binding proteins so that the 
mismatch-specific bands could be observed, it cannot be conclusively stated whether the 
complexes are pre-formed in the absence of DNA.
To further determine the nuclear protein-DNA interactions, UV cross-linking 
experiments were performed. In these experiments nuclear extracts were incubated with 
5’ [32P] -labeled heteroduplex or homoduplex oligonucleotides, the proteins were UV 
cross-linked to the DNA, and then antibodies against five o f the mismatch repair proteins 
were used for separate immunoprecipitations. The immunoprecipitated proteins that
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Figure 14 -  hMSH2 and hM LHl Immunoprecipitation in the Absence of 32-mer 
oligonucleotide DNA. HeLa nuclear extracts were incubated in the absence of 5’ [32P] - 
labeled 32-mer oligonucleotide. Proteins were UV treated and immunoprecipitation was 
performed with antibody against hMSH2 and hM LHl, simultaneously. Following SDS- 
polyaery 1 amide electrophoresis and transfer to nitrocellulose, Western blotting was 
performed with the indicated antibody probes (Western ab). Chemiluminescence was 
used for detection with sequential stripping of the membrane between probes.
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Figure 15 - UV Cross-linking and Immunoprecipitation of Protein-DNA Complexes.
The 5’ [32P] -labeled 32mer oligonucleotide duplex containing GC (homoduplex) or GT 
(heteroduplex) was incubated with HeLa nuclear extracts and bound proteins were UV 
cross-linked to the DNA. Immunoprecipitation was performed with the indicated 
antibodies (IP antibody) and the immunoprecipitates were electrophoresed on an SDS- 
polyacrylamide gel. The figure is an autoradiogram of the resulting gels. Arrows 
indicate the five observed bands (hMSH6, hMSH2 and proteins that run to the 
approximate position of 115 kDa (A), 95 kDa (B) and 50 kDa (C) bound to 5’ [32P]- 
labeled oligonucleotides.
became UV cross-linked to the 5’ [32P] -labeled oligonucleotides were observed by 
autoradiograph o f the resulting denaturing polyacrylamide gel (Figure 15). When 
antibodies against hMSH2, hMSH6, hM LHl, hPMS2 or hPMSl were used for 
immunoprecipitation the same four proteins (hMSH6, A, B, and C) became bound to the 
mismatched DNA and not to the homoduplex DNA. This is consistent with the binding 
pattern observed in Figure 10A. The predominant mismatch-specific DNA binding 
activity is that o f hMSH6 as identified in Figure 10, regardless of the antibody used for 
immunoprecipitation. The degree of binding by hMSH6 is greater when antibody against 
hMSH6 is used in a direct immunoprecipitation than when hMSH6 is co- 
immunoprecipitated using antibodies against hMSH2, hM LHl, hPMS2 or hPM Sl. This 
is the expected result as during the co-immunoprecipitations the protein-protein 
interactions can potentially be easily disrupted, and thus further confirms that this band 
represents hMSH6. Alternatively, it is possible that the intensity of the hMSH6 band 
from the hMSH6 immunoprecipitation results from there being hMSH6 homomultimers 
bound to the oligonucleotides in addition to the larger mismatch repair complexes. 
However, this is unlikely as studies using purified hMSH6 have shown it to be incapable 
of binding to DNA when not interacting with hMSH2 in the hM utSa heterodimer (117). 
The amount of hMSH6 UV cross-linked to the heteroduplex when antibody against 
hMSH2 is used for immunoprecipitation is greater than that seen when antibody against 
hPMS2, hPMSl or hMLHl is used for immunoprecipitation. This could be because the 
hM utSa complex alone binds to the mismatched DNA, in addition to binding of the
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larger mismatch repair complexes or could reflect the strength o f the protein-protein 
interaction between hMSH2 and hMSH6.
When antibody against hMSH2 is used to immunoprecipitate, in addition to the 
four bands discussed above a unique band is observed of approximately 110 kDa that 
runs to approximately the same position as hMSH2 as indicated on the Western Blots in 
Figure 10, Figure 11 and Figure 12. Other investigators have demonstrated purified 
hMSH2 to be capable of specifically binding to mismatched DNA when not part of the 
hM utSa heterodimer (112, 113) and as well the hMutSP heterodimer (hMSH2 and 
hMSH3) can bind to mismatched DNA, although this interaction is believed to occur via 
hMSH3, not hMSH2 (109). As bound hMSH2 cannot be co-immunoprecipitated with 
antibodies against any o f the other mismatch repair proteins it appears that hMSH2 does 
specifically bind to mismatched DNA, but only when not associated with hMSH6.
2. Protein interactions after addition o f  A TP
The effects of ATP on the mismatch repair protein interactions were also 
examined. Nuclear extracts were incubated with 5 ’ [32P] -labeled heteroduplex or 
homoduplex oligonucleotides and the proteins were UV cross-linked to the DNA as 
above, except that 0.1 mM ATP was added after incubation o f the nuclear extract with
32the 5’ [ P] -labeled DNA, but prior to UV cross-linking. The samples were then run on a 
denaturing polyacrylamide gel and examined by autoradiography to detect bound 
proteins. In Figure 16, antibodies against hMSH6 and hMLHl were used to
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Figure 16 - UV Cross-linking and Immunoprecipitation in the Absence or Presence 
of ATP. The 5’ [32P] -labeled oligonucleotides containing GC (homoduplex) or GT 
(heteroduplex) were incubated with HeLa nuclear extracts. 0.1 mM ATP was added to 
samples in Lanes 2, 4 and 6, and bound proteins were UV cross-linked to the DNA. 
Immunoprecipitation was then performed using antibodies against the indicated proteins 
(IP antibody). After SDS-polyacrylamide electrophoresis, the resulting gel was dried and 
exposed to film. Arrows indicate hMSH6 and proteins that run to approximately 115 
kDa (A), 95 kDa (B) and 50 kDa (C) bound to 5’ [32P]-labeled oligonucleotides and 
unbound oligonucleotides at the bottom of the gel that have co-immunoprecipitated.
immunoprecipitate proteins UV cross-linked to 5’ [32P] -labeled oligonucleotides with 
and without addition of ATP. When ATP is not added, the same mismatch-specific 
bands are seen as in Figure 10A and Figure 14 (hMSH6, A, B, and C). The amount of 
hMSH6 that is bound to the mismatched substrate decreases upon addition of ATP, 
regardless of the mismatch repair antibody used for immunoprecipitation. This correlates 
with previous studies that have shown hM utSa to disassociate from oligonucleotide 
substrates upon binding of ATP to the protein complex (108, 120 - 122). As well, when 
antibody against hMSH6 is used for immunoprecipitation after the addition of ATP, the 
amount of binding to the mismatched DNA by the A, B and C proteins also decreases. 
Binding by hMSH6 does not completely disappear when antibody against hMSH6 is used 
for immunoprecipitation in these experiments using 0.1 mM ATP. ATP concentrations 
of 10 mM do, however, completely obliterate hMSH6 binding (results not shown).
Interestingly, a novel interaction between hMLHl and the heteroduplex DNA is 
detected when ATP is added to the nuclear extract-DNA incubation. As seen by 
comparing Figure 16, Lanes 5 and 6, when ATP is added to an hMLHl 
immunoprecipitation, the amount of unbound mismatched oligonucleotide that co­
precipitates increases, as evidenced by the increased amount o f oligonucleotide detected 
at the bottom of the gel. This occurs specifically with the heteroduplex and not the 
homoduplex oligonucleotide (Lanes 1 and 2). This phenomena does not occur when 
antibody against any of the other mismatch repair proteins are used (Lanes 3 and 4 and 
results not shown). hMLHl itself does not become directly UV cross-linked to the DNA 
as a band at the expected 80 kDa site is not observed. However, the amount of labeled
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DNA bound to the B and C proteins does increase. hM LHl, therefore, participates in an 
interaction with the heteroduplex DNA after addition of ATP. This interaction appears to 
include the B and C proteins but does not appear to involve a direct interaction between 
hMLHl and the mismatched oligonucleotide.
To compare the protein-protein interactions in the mismatch repair complex after 
addition of ATP, nuclear extracts were incubated with 5’ [32P]-labeled oligonucleotides, 
0.1 M ATP was added, bound proteins were UV cross-linked to the DNA and the 
samples were immunoprecipitated with antibodies against the various mismatch repair 
proteins. These immunoprecipitates were then run on a denaturing polyacrylamide gel, 
transferred to a nitrocellulose membrane and blotted with antibodies against the 
mismatch repair proteins. As seen in each Lane 3 of Figure 10B, when antibody against 
hMSH6 is used for immunoprecipitation in the presence o f ATP, hM LHl, hPMS2 and 
hPMSl no longer co-immunoprecipitate with hMSH6. The only protein-protein 
interaction that remains after addition of ATP is that between hMSH2 and hMSH6 
(hMutSa). This is confirmed in Lanes 2 and 4 of the hMSH2 immunoprecipitation 
shown in Figure 12, where only hMSH6 co-immunoprecipitates after addition of ATP.
In Lane 3 of Figure 11 it can be observed that all interactions between hMLHl and the 
hMSH6, hMSH2, hPMS2 and hPMSl mismatch repair proteins are disrupted after 
addition of ATP. In Figure 12 it can also be seen that the protein interactions observed in 
the presence o f homoduplex DNA are also disrupted after addition of ATP (Lane 2), 
demonstrating that the presence of a mismatch is not necessary for the conformational 
changes to occur in the proteins that result in the loss of the protein-protein interactions.
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The lack of protein-protein binding seen after addition of ATP in Figures 10, 11, and 12 
also confirms that the observed co-immunoprecipitations are the result of specific 
mismatch repair protein interactions, as ATP is known to bind to and modulate these 
proteins (108, 120 - 122).
3. Comparison o f  mismatch repair protein interactions with G:A and G:T mismatches at 
codons 10 and 12
In the above experiments the binding of mismatch repair proteins was examined 
for the efficiently repaired G:T mismatch at codon 10 to determine a putative normal 
pattern of interaction. In the experiments presented here mismatch repair protein binding 
to oligonucleotide substrates was determined for G:T and G:A mismatches. As well, 
mismatch repair protein binding was compared at both the codon 10 and 12 location. 
Oligonucleotides were prepared as described, nuclear extracts were incubated with a 
mixture containing equal counts per minute of the 5’ [32P]-labeled mismatched 
oligonucleotide together with unlabeled homoduplex competitor, and bound nuclear 
proteins were UV cross-linked to the DNA substrates. The samples were then 
immunoprecipitated using antibody against hMSH6 or hMSH2. Immunoprecipitation 
with antibodies against hM LHl, hPMS2 and hPMSl is not shown as they generate results 
similar to (but weaker than) that seen with hMSH6 immunoprecipitation (Figure 15). 
After immunoprecipitation the samples were run on a denaturing polyacrylamide gel and 
the gel was dried and exposed to film overnight.
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Figure 17 -  DNA-Protein UV Cross-linking and Subsequent Immunoprecipitation 
to G:T and G:A Mismatches at Codon 10 and Codon 12. The 5’ [32P] -labeled 
oligonucleotides containing G:T or G:A mismatches at either codon 10 or codon 12 were 
incubated with HeLa nuclear extracts. Immunoprecipitation was then performed using 
antibodies against the indicated proteins (IP antibody). After SDS-polyacrylamide 
electrophoresis, the resulting gel was dried and exposed to film. Arrows indicate 
hMSH6, hMSH2 and proteins that run to approximately 115 kDa (A), 95 kDa (B) and 50 
kDa (C) bound to 5’ [32P]-labeled oligonucleotides.
When antibody against hMSH6 was used for immunoprecipitation (see Figure 17, 
Lanes 6 - 9) the same four bands (hMSH6, A, B and C proteins) as seen in Figure 15 are 
detected for G:T mismatches at codon 10, confirming the previous results. As predicted, 
there is more hMSH6 bound to G:T mismatches at the codon 10 position (Lane 6) than to 
G:T mismatches at the codon 12 position (Lane 7). As well, the amount of hMSH6 
binding seen in Lanes 6 and 7 for G:T mismatches is greater than that detected in Lanes 8 
and 9 for G:A mismatches. This is in agreement with the gel-shift experiments and with 
reports on the binding affinities of purified hM utSa by other investigators (237). 
Uniquely, there is almost no binding by the B mismatch-specific protein when using an 
oligonucleotide with a G:T mismatch at the codon 12 position (Lane 7) while this band is 
seen clearly when using an oligonucleotide with a G:T mismatch at the codon 10 position 
(Lane 6). This lack of binding by the B protein at codon 12 may possibly reflect an 
inability to assemble a larger repair protein complex or an inability to proceed to 
subsequent events in the repair process.
Antibody against hMSH2 was also used for immunoprecipitation after UV cross- 
linking of bound protein to the oligonucleotide substrates (Lanes 2 - 5). When using 
oligonucleotides with a G:T mismatch at codon 10, five bands are detected (hMSH6, 
hMSH2, A, B, and C proteins), as in Figure 15. As seen previously, hMSH2 bound to 
oligonucleotide is only detected when antibody against hMSH2 is used for direct 
immunoprecipitation, confirming that although hMSH2 can bind to mismatched DNA, it 
only does so when not participating in the larger mismatch repair protein complex. When 
antibody against hMSH2 is used for the immunoprecipitation the amount of hMSH6 and
93
hMSH2 that is found UV cross-linked to the oligonucleotides with a G:T mismatch at 
codon 10 is greater than the amount UV cross-linked to oligonucleotides with a G:T 
mismatch at codon 12 (Lanes 2, 3). This again suggests a general inability of the 
mismatch repair proteins to bind to and/or recognize mispairs at the codon 12 location. 
Interestingly, hMSH6 is detected UV cross-linked to oligonucleotides with G:A 
mismatches at the codon 12 position (Lane 5), but not when the mismatch is located at 
the codon 10 position (Lane 4). This unusual result was consistently detected when these 
experiments were repeated. It therefore appears that mismatch repair proteins are able to 
bind to G:A mismatches at the codon 12 position that are not able to bind to G:A 
mismatches at the codon 10 position. This result is especially intriguing as hMSH6 UV 
cross-linked to the oligonucleotide was not detected when antibody against hMSH6 was 
used for a direct immunoprecipitation with the same mismatched oligonucleotide (Codon 
12, G:A) in Lane 9. One possible explanation for these results is that the hMutSa 
heterodimer binds to oligonucleotides with a G:A mismatch at codon 12 in an unsual 
configuration. As the anti-hMSH6 antibody used was monoclonal it is possible that this 
antibody cannot immunoprecipitate hMSH6 if the protein is in a different three- 
dimensional conformation. This would explain the inability o f monoclonal antibody 
against hMSH6 to directly detect the hMSH6-DNA interaction in Lane 9, as compared to 
the ability o f the polyclonal antibodies against hMSH2 to co-immunoprecipitate bound 
hMSH6 in Lane 5.
95
IV. Discussion
Although the existence of hotspots of mutation at oncogenic locations has been 
well documented, the mechanisms contributing to the increased mutation frequency at 
these hotspots within human tumors are still in question. The experiments presented here 
have examined whether inefficiencies and/or inaccuracies in repair of mismatched DNA 
can contribute to the increased rate of mutation at a hotspot. The relative efficiency of 
mismatch repair at a non-hotspot of mutation (H-ras codon 10) was compared to 
previously determined repair rates at a nearby oncogenic hotspot o f mutation (H-ras 
codon 12). These results demonstrate that for the biologically relevant codon 12 location 
of W-ras there is inefficient repair of specific mismatched base pairs. Furthermore, these 
experiments demonstrate that the repair rates for mismatched nucleotides vary depending 
on the precise location and exact composition of the mismatch.
The results for in vivo mismatch repair at the middle nucleotide position of codon 
10 indicate that G:A, A:C and T:C mismatches at this location are repaired more 
efficiently than when located at the codon 12 middle nucleotide hotspot of mutation (see 
Table 3 and Figure 6 for comparison). As the only difference when comparing repair 
rates for each specific mismatch at these two locations is the sequence context 
surrounding the codon containing the mismatch, these results indicate for the first time 
that sequence context can effect a cell’s ability to repair mispaired DNA. These results 
are analagous to studies in which differential nucleotide excision repair at hotspots of 
mutation has been observed (214, 215, 226). Indeed, in studies examining repair of O6-
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methylguanine adducts opposite thymine a consensus sequence for lack of repair was 
derived that has significant similarity to the sequence surrounding codon 12 of H-ras 
(226). It is also intriguing that previous primer extension studies have demonstrated that 
both DNA polymerase (3 and a  to have a strong pause site at the wild-type codon 12 
location (210), suggesting stearic hindrance, a difficulty in the gap filling stage of 
different DNA repair processes, or a general difficulty in enzymatic reactions at this site.
In agreement with previous studies differences in the repair rates were observed 
when the various mismatches (G:T, T:C, A:C, G:A) were located at the same codon 10 
position. This indicates that different mismatches are repaired at different efficiencies, 
even when at the same location (175, 178, 233 - 235). As seen in Table 3, only 69% of 
G:A mismatches were correctly repaired at codon 10 in NIH 3T3 cells, while A:C, T:C 
and G:T were all repaired at a high rate (94%-96%) at this location. Previously, G:A 
mismatches were found to be repaired at the even lower rate of 35% at codon 12 in NIH 
3T3 cells (227). Other investigators have also found G:A to be particularly difficult to 
repair in both in vitro and in vivo mismatch repair studies (178, 233 - 235). It appears 
that there are slower kinetics repair specifically for G:A mismatches. Lack of repair of 
G:A mismatches at codon 12 in H-ra.s may be biologically relevant, as the resulting T:A 
transversion is a common activating mutation found at this location in naturally occurring 
human tumors (203 - 205).
Furthermore, in each case when repair to the wild-type sequence (G:C) did not 
occur, a mixture of cells within each colony containing G:C and A:T or T:A mutated 
sequences were observed. Such mixtures most probably result from replication prior to
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repair of the single mismatch-containing plasmid in the originally transfected cells. 
Therefore, in this experimental system there is a decreased efficiency in the kinetics of 
repair for specific mismatches at specific locations, rather than inaccurate repair leading 
to mutation.
Gel-shift analysis using nuclear extracts was then performed to determine if 
binding by specific DNA mismatch repair proteins could be impaired for particular 
mismatches at codon 10 or codon 12. As seen when comparing Figure 6 and Figure 7C, 
the relative amount of mismatch-specific binding to each mismatch at codon 12 using 
NIH 3T3 nuclear extracts correlates with specific mismatch repair abilities. The 
observed binding in NIH 3T3 nuclear extracts and the slower migrating band in HeLa 
nuclear extracts is believed to be due to the long-patch mismatch repair hM utSa complex 
as: (1) this has been shown to be the major mismatch binding activity in HeLa nuclear 
extracts (80) (2) pre-incubation of nuclear extract with antibody to hMSH6 destroyed this 
binding (117) and (3) addition of ATP, which has been shown to disrupt binding of the 
hM utSa complex (108, 120 - 122), resulted in a complete lack of binding by the 
mismatch-specific factors. Although other mismatch-specific binding factors (DNA 
topoisomerase I, deoxyinosine 3’ endonuclease and human exonuclease I) have been 
reported (238, 239, 168) these do not bind to DNA with the same sequence specificity 
and do not exhibit the same sensitivity to ATP.
It is interesting to note that in the gel-shift experiments with HeLa nuclear 
extracts two mismatch-specific bands were observed (Figure 7A). Although only the 
slower migrating band was disrupted by pre-incubation with antibody against hMSH6,
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both binding activities were disrupted by addition of ATP (Figure 8). A recent paper has 
demonstrated that hMutS(3 releases from DNA upon addition of ATP (135). Binding by 
purified hMSH2 homodimers is also modulated by ATP (112, 113). As well, both the 
hMutSP heterodimer (229 kDa) and an hMSH2 homodimer (204 kDa) would be expected 
to migrate faster than hM utSa (262 kDa), although migration rates on non-denaturing 
polyacrylamide gels do not always correlate with molecular weight. It is therefore 
possible that the faster migrating band in the HeLa gel-shift experiments is the 
hMutSfi heterodimer or an hMSH2 homodimer bound to the mismatched 
oligonucleotides. This band was not observed in the gel-shift experiments using NIH 
3T3 nuclear extracts. However, somewhat different nuclear extract buffers and binding 
buffers were used in the experiments involving NIH 3T3 nuclear extracts as compared to 
the experiments involving HeLa nuclear extracts. Therefore the lack of binding by the 
second mismatch-specific band in NIH 3T3 nuclear extracts could reflect a difference 
between murine and human proteins in the different conditions. Alternatively, if the 
faster migrating band seen when using HeLa nuclear extracts represents hMutSP bound 
to the mismatched oligonucleotide, than it could be missing in the experiments with NIH 
3T3 nuclear extracts if these cells are lacking a MSH3 activity.
In HeLa nuclear extracts binding by hM utSa (slower migrating band) was 
observed with oligonucleotides that contain G:A at the codon 10 position but not with 
oligonucleotides with G:A at the codon 12 position. This demonstrates that the sequence 
context surrounding a mismatch can effect hM utSa binding. Local sequence context 
effects on hM utSa binding have also been recently demonstrated for mismatches and one
and two base pair loop structures (237, 240). The observed lack o f binding to 
oligonucleotides containing G:A mismatches at codon 12 correlates with the very low 
efficiency of repair observed in vivo for G:A mismatches at codon 12. Other 
investigators have demonstrated that hM utSa recognizes and binds to mismatched DNA 
when in an ADP-bound form and that subsequent ATP binding results in dissociation 
from or translocation off the mismatched oligonucleotide substrate (121, 125, 126). This 
had led to the suggestion that repair is modulated by ATP binding rather than mismatch 
recognition. However, our studies would suggest that at sensitive locations such as the 
H-ras codon 12 hotspot of mutation, there may be deficiencies in recognition of specific 
mismatches that result in low levels of repair. Recently, deficiencies in hM utSa binding 
were demonstrated in a number of human lung cancer cell lines that expressed both 
hMSH2 and hMSH6, indicating that a lack of hM utSa binding may indeed be relevant in 
tumors (241).
The lower rates of repair for a variety of different mismatches (T:C, A:C, G:A) at 
codon 12 in NIH 3T3 cells combined with the differential binding by hM utSa implicates 
an inefficiency in general in the long-patch mismatch repair system at this hotspot, rather 
than inaccurate repair. There appears to be slower kinetics o f recognition and/or repair at 
codon 12 as compared to codon 10, rather than a completely nonfunctioning long-patch 
mismatch repair system at this location. Variable kinetics of repair that result in altered 
in vivo repair rates due to plasmid replication before repair have been previously 
observed in studies using DNA adducts (242). Taken together, the above results suggest
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that codon 12 is a hotspot of mutation, ai least in part, due to a rate limiting step in 
recognition and/or binding to mismatches.
In the next phase of these studies UV-crosslinking, immunoprecipitation, and 
Western blotting were perfomed using HeLa nuclear extracts to identify the proteins 
bound to the mismatched oligonucleotide substrates and to determine the mismatch repair 
protein-protein interactions. In these studies protein interactions were observed between 
the human MutS homologs hMSH2 and hMSH6 and the human MutL homologs hMLHl, 
hPMSl and hPMS2. These interactions occur in the absence of ATP, thus ATP binding 
or hydrolysis is not a pre-requisite for complex formation in HeLa nuclear extracts in 
these experiments. Although we observe both hPMS2 and hPMS 1 in the complex, they 
do not co-immunoprecipitate each other. Therefore the mismatch repair complex 
involves either hPMS2 or hPM Sl, but not both together (see Figure 18). This is in 
agreement with a recent publication that describes the hMutLP complex of hMLHl and 
hPMSl as distinct from the hM utLa complex of hMLHl and hPMS2 (159). This is also 
the first report of hPMSl interaction with the MutS homologs. These results indicate that 
either hMutLa or hMutLP is capable of interacting with hM utSa and binding to 
mismatched DNA. If these complexes are at least partially functionally redundant, this 
would explain the rarity of HNPCC kindreds with mutations in hPMS2 or hPMSl (11).
It has been suggested that the hM utLa heterodimer functions with the hM utSa 
heterodimer in repair of mismatches and conversely the hMutLp heterodimer functions 
with the hMutSP heterodimer in repair of small insertion-deletion loops. However, in 
these experiments both the hPMSl protein (hMutLP) and the hPMS2 protein (hMutLa)
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Figure 18 -  Proposed Mismatch Repair Protein Interactions.
co-immunoprecipitate with hMSH2 and hMSH6 (hMutSa). Although it is possible that 
hMutLp may be able to interact with hM utSa in a manner that is not functionally 
relevant, it is also possible that the different complexes both interact with hM utSa and 
have distinct, as yet unknown functions in the repair process. In support of this, the 
phenotypes o f HNPCC patients that carry mutations in hPMS2 or hPMSl are similar, 
suggesting that the proteins have distinct roles in the mismatch repair process (8). 
Possibilities for such functions include translocation, strand discrimination and assembly 
with endonucleases or other proteins involved in repair of mismatches.
The protein-protein interactions in nuclear extracts occur in the presence of 
homoduplex and heteroduplex DNA as well as in the absence of the 32-mer 
oligonucleotides (Figures 10 -  14). However, the protein complex binds specifically only 
to heteroduplex substrates as detected by UV cross-linking (Figure 10 and Figure 15-17). 
As previously reported (120), hMSH6 appears to be the predominant DNA binding 
protein in this complex although binding by the A, B and C proteins was also observed. 
Interestingly, the position of the A mismatch binding protein is similar to that of hPMS2 
and hPMSl as identified by Western blotting. Further studies are necessary to determine 
if either hPMS2 or hPMSl has an as yet unidentified DNA binding activity which allows 
it to become UV cross-linked to the heteroduplex DNA when in the mismatch repair 
protein complex or perhaps to function in subsequent steps in the repair process.
However, we do not see a stronger A band when either hPMS2 or hPMS 1 is used for
direct precipitation (Figure 15, Lanes 9 and 11) as compared to the co- 
immunoprecipitations (Figure 15, Lanes 3, 5 and 7). If  the A band represents either 
hPMS2 or hPMS 1, a stronger band would be expected when using antibody directed 
specifically against the protein, compared to a co-immunoprecipitation (during a co- 
immunoprecipitation the non-covalent protein-protein interactions can easily be 
disrupted). This suggests that the 115 kDa band represents a distinct protein. Other 
investigators have also identified an unknown protein of approximately 115 kDa cross- 
linked to heteroduplex DNA (4). The position of the B band may correlate with human 
exonuclease 1 (94 kDa) (168). This 5’ ->  3’ exonuclease has previously been shown to 
physically interact with hMSH2 in human nuclear extracts (168), and genetic studies in 
yeast have shown the yeast homolog to function in the same epistatic pathway as hMSH2 
(169, 170). As well, the B band may represent DNA topoisomerases I, a frequently 
observed mismatch-specific binding protein of 90 kDa, although this protein has not yet 
been reported to function in mismatch repair (238). The size of the C band correlates 
with the reported sizes of RPC II, III, IV and V subunits (37 kDa, 36 kDa, 40 kDa and 38 
kDa, respectively) (173). It is also very probable that there will be more proteins 
identified in the mismatch repair process in humans. For instance, a DNA helicase and a 
3 ’ ->  5 ’ exonuclease have yet to be reported as involved in human mismatch repair, yet 
based on the E. coli model it is expected that such proteins will be necessary in human 
mismatch repair (81). The identification of these three unknown mismatch binding 
proteins is therefore of great interest in clarifying the proteins involved in mismatch 
recognition and repair.
hMSH2 is also observed to become UV cross-linked to the heteroduplex DNA, 
but only when antibody against hMSH2 is used for direct immunoprecipitation (Figure 
15). As this mismatch-specific DNA binding activity of hMSH2 does not co- 
immunoprecipitate with hMSH6, hM LHl, hPMS2, or hPMSl it can be concluded that 
hMSH2 is able to bind to mismatched DNA, but only when not participating in the larger 
mismatch repair protein complexes identified here. One possibility could be that the 
hMSH2-DNA interaction occurs when hMSH2 is bound to hMSH3 in the hMutSp 
heterodimer. Alternatively, as studies with purified hMSH2 have shown it to bind to 
mismatched oligonucleotides as a homomultimer (112, 113), the observed band could be 
due to an interaction between hMSH2 homomultimers and the mismatched substrate in 
nuclear extracts. It is interesting to note that in the gel-shift experiments with HeLa 
nuclear extracts two mismatch-specific bands were observed (Figure 7A). 
Immunoprecipitation using antibody against hMSH3 would answer whether the observed 
activity is hMutS(3 or hMSH2 homodimers. Unfortunately, such antibodies are not yet 
available, although it is expected that they will be in the near future.
After addition of ATP to the mixtures the protein-protein interactions between 
hMLHl and hPMSl or hPMS2 are disrupted as well as the interactions between these 
proteins and the hM utSa heterodimer (Figures 10 -  13). The only protein-protein 
interaction that can be observed after addition of ATP is that between hMSH2 and 
hMSH6 (hMutSa). This is in conflict with yeast studies which have reported that the 
PMS1, MSH2 and MSH6 complex either remains intact upon addition o f ATP (162) or 
that the protein interactions increase in the presence of ATP (163 - 164). The most
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probable explanation for this apparent discrepancy is that the previous studies used 
purified proteins while these experiments were performed using whole nuclear extracts.
In the presence of ATP, the mismatch repair proficient HeLa nuclear extracts can proceed 
with the repair process resulting in the eventual disruption of the protein-protein 
interactions. The excess of ATP then prevents re-formation of the protein complex. 
Although the reactions were maintained at 0°C - 4°C throughout, the reactions were first 
incubated for 40 minutes and then after UV cross-linking the immunoprecipitations were 
performed overnight, allowing some time for the mismatch repair processes to occur, 
even at these sub-optimal conditions. Alternatively, it has been shown in E. coli that a 
mismatch-containing DNA substrate of sufficient size is necessary for MutS and MutL to 
interact in the presence of ATP (89). In these experiments the relatively small size of the 
oligonucleotide substrate used (32-mer) could inhibit the ability o f the MutS and MutL 
homologs to form a complex with each other and with the DNA after the addition of 
ATP. In Figure 16, addition of ATP also decreases the amount o f hMSH6 that becomes 
UV cross-linked to the DNA. This is in agreement with numerous studies involving 
purified hMSH2 and hMSH6 that have determined that the purified hM utSa heterodimer 
disassociates from mismatch-containing oligonucleotides upon binding of ATP (108, 120 
- 122).
Anytime the proteins interact with the 5’ [32P] -labeled DNA, increased amounts 
of free oligonucleotide will be observed at the bottom of the gel after 
immunoprecipitation. This is due to the less than 100 % efficiency o f the UV cross- 
linking reactions. Oligonucleotide that interacts with the protein will be co-
immunoprecipitated, and if the DNA is not UV cross-linked to the protein it will become 
unbound during denaturing gel electrophoresis. Therefore, the amount of free 
oligonucleotide observed correlates with the protein-DNA interactions (see for example 
Figure 15). However, in Figure 16 a novel interaction is observed between hMLHl and 
the mismatched DNA after addition o f ATP. Antibody against hMLHl is capable of co- 
immunoprecipitating increased amounts of the 5 ’ [32P] -labeled heteroduplex 
oligonucleotides (seen free at the bottom of the gel in Lane 6), as compared to the amount 
of co-immunoprecipitated oligonucleotide observed with 5’ [32P] -labeled homoduplex 
DNA (Lane 2). This occurs even though there is relatively little protein UV cross-linked
32to the 5’ [ P] -labeled oligonucleotide in Lane 6. Therefore, hMLHl may participate in 
another mismatch repair protein complex that interacts specifically with mismatched 
DNA after addition of ATP. This complex does not appear to involve hMSH6, hMSH2, 
hPMS2 or hPMS 1 as antibodies against these proteins do not co-immunoprecipitate 
increased amounts of the to 5’ [32P] -labeled DNA after addition of ATP. hMLHl does 
not interact directly with the DNA as it does not become UV cross-linked to the 
oligonucleotide and 5 ’ [32P] -labeled heteroduplex is found free at the bottom of the gel 
after denaturing gel electrophoresis. Therefore, hMLHl appears to participate in a novel 
protein complex in which other proteins directly interact with the mismatched 
oligonucleotide (see Figure 18). Other investigators have failed to observe direct 
interactions between mismatch-containing DNA and the purified hMutLa heterodimer 
(158). This is understandable if the complex involves additional nuclear proteins which 
directly interact with the heteroduplex DNA and that have not as yet been identified.
Mismatch-specific binding by the B and C proteins does continue to be observed, making 
these proteins candidates for participation in this novel complex.
This finding suggests that hMLHl plays a role in steps in the repair process 
subsequent to mismatch recognition. Although little is known in regard to the exact 
biochemical role o f hMLHl in humans, a number of studies in E. coli have shed some 
light on the subject. One suggested role for MutL is to facilitate the interactions between 
MutS and proteins necessary for subsequent steps in the repair process such as MutH and 
DNA helicase II (83, 92, 96 - 98). hM LH l’s ability to participate in the initial complexes 
involving hM utSa as well as in the novel complex after addition o f ATP suggests that it 
may have an analogous role in human mismatch repair. As well, recent studies have 
suggested that MutL acts as a molecular chaperone. This hypothesis arises from MutL’s 
observed homology to the molecular chaperone molecule Hsp90 (102) and recent X-ray 
crystallography studies which have shown it to bind ATP and have a weak ATPase 
activity (103, 104). In the crystallography studies the MutL protein was observed to 
undergo conformational changes upon ATP hydrolysis which are likely to modulate the 
interactions between MutL and the other components of the repair machinery. With 
hMLHl, conformational changes upon ATP hydrolysis could result in the different 
protein-protein and protein-DNA interactions observed in these studies after addition of 
ATP to the reaction.
Genetic analysis o f HNPCC kindreds has demonstrated the importance of the 
hMLHl gene product in mismatch repair with approximately 61% of HNPCC kindreds 
reported as of May 1999 carrying mutations in the hMLHl gene (11). The central role of
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hMLHl in both the hM utLa and hMutLp heterodimers (with hPMS2 and hPM Sl, 
respectively) (158, 159) and as observed in these studies in the two mismatch repair 
protein complexes helps to explain this genetic data. As well, the novel interaction 
observed in these studies between hMLHl and heteroduplex DNA after addition of ATP 
suggests that hMLHl may have a further unique role in steps in mismatch repair 
subsequent to mismatch recognition.
These results suggest a model for human mismatch repair whereby the hMutSa 
heterodimer, either alone or already in a complex with either hM utLa or hMutL[3, 
recognizes and binds to mispairs (see Figure 18). The formation o f these protein-protein 
complexes occurs in nuclear extracts in the absence o f additional ATP. The complex can 
then stably bind to mismatched DNA, again in the absence o f ATP. This protein-DNA 
complex consists of hMSH2, hMSH6, hMLHl and either hPMS2 or hPM Sl, with 
possible distinct functions for each complex. In the presence o f ATP, conformational 
changes occur resulting in the eventual release of the protein complex from the 
heteroduplex oligonucleotides used in these studies and hM LH l’s dissociation from 
hMutSa and hPMS or hPMS 1. hMLH 1 is then capable o f further interaction with the 
mismatched DNA in a novel manner, presumably playing a role in subsequent steps in 
the repair process. In this model the hM utSa heterodimer would serve to recognize 
mismatches and bring the MutL homologs to the site, either as a preformed complex or 
by recruiting the MutL homologs. After interaction with ATP, a complex involving 
hMLHl assembles. hMLHl would in this model be functioning as a molecular 
matchmaker between the initial recognition complex that involves hM utSa and the later
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protein complex that presumably actuates repair. This is homologous to E. coli where it 
is known that MutL interaction with MutS is necessary to assemble MutH and DNA 
helicase II in the mismatch repair protein complex (96 - 99).
As a final experiment the mismatch repair protein-DNA interactions were 
examined for G:A and G:T mismatches located at either codon 10 or codon 12. As 
predicted from the gel-shift experiments, hMSH6 binds more efficiently to G:T 
mismatches at the codon 10 position than when the mismatch is located at codon 12 
(Figure 17). Also, when antibody against hMSH6 is used for immunoprecipitation, more 
hMSH6 is found bound to G:T mismatches than to G:A mismatches. This is in 
agreement with reports from other investigators (237,240). Once again, the observed 
degree o f binding by hMSH6, and therefore hM utSa, correlates with the efficiency of 
repair in vivo at these locations.
Binding by the B mismatch-specific protein was observed for G:T mismatches at 
codon 10 but interestingly not for G:T mismatches at codon 12 when antibody against 
hMSH6 is used for immunoprecipitation (Lane 7). This is surprising as there is 
detectable binding by hMSH6 and the A and C proteins at the codon 12 site. Therefore, 
even if mismatch recognition by hM utSa has occurred at the codon 12 location as 
detected by hMSH6 binding, assembly of the larger mismatch repair protein complex or 
subsequent steps in the repair process may be in some way impaired. This would be 
reflected in the lowered efficiency o f repair generally seen at the codon 12 location as 
compared to the codon 10 location. G:T mismatches, however, could still be repaired 
efficiently due to the separate base excision repair pathway that exists to repair this
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mismatch. The identity and function of the B protein will be important in determining if 
this result reflects an inability to proceed with mismatch repair at H-ras codon 12.
hMSH2 binding was also examined by directly immunoprecipitating with 
antibody against this mismatch repair protein. As seen previously, hMSH2 can become 
UV cross-linked to the DNA only when not participating in the hM utSa complex as 
hMSH2 is only seen bound to the mismatched oligonucleotides when antibodies against 
hMSH2 are used for direct immunoprecipitation. There is more binding by hMSH2 
detected for G:T mismatches at codon 10 than at codon 12, similar to the results for 
hMSH6 binding. This supports the hypothesis that there is a generalized difficulty in 
recognition and/or binding at the codon 12 location.
Unexpectedly, an increased binding by hMSH6 is observed for G:A mismatches 
at codon 12 as compared to G:A mismatches at codon 10 (Lanes 4 and 5). Increased 
amounts of hMSH6 binding to G:A mismatches at codon 12 as compared to codon 10 is 
observed only when antibody against hMSH2 is used for immunoprecipitation, and not 
when antibody against hMSH6 is used (compare Lanes 4 and 5 with Lanes 8 and 9). This 
finding was reproducible when these experiments were repeated. It therefore appears that 
although binding by hM utSa is possible for G:A mismatches at the codon 12 site, the 
hMutSa configuration is aberrant in that antibody against hMSH6 cannot detect it. 
Although the anti-hMSH6 antibody used was polyclonal, it is possible that a 
conformational change could affect the antibody’s ability to bind to the protein. The 
observed binding by hMSH6 to G:A mismatches at codon 12 could then represent an 
unusual conformational configuration of the hM utSa heterodimer that the anti-hMSH6
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antibody cannot detect. The anti-hMSH2 antibodies are polyclonal and are able to bind 
to hMSH2. In this way they co-immunoprecipitate hMSH6, as seen in Lane 5. Based on 
the relatively low efficiency o f repair for G:A mismatches at codon 12 in vivo, this 
proposed conformation of hM utSa may represent a dead-end in the repair process.
The importance of understanding mechanisms of site-specific mutation is 
demonstrated by the prevalence of hotspots of mutation in naturally occurring tumors. In 
these studies cellular mismatch repair rates for mismatches at a non-hotspot location were 
determined and compared to previously determined rates of repair for the same 
mismatches at an oncogenic hotspot of mutation. From these results it can be concluded 
that H-ras codon 12 is a hotspot of mutation, at least in part, due to deficiencies in 
mismatch repair. It was also shown that surrounding sequence context can effect rates of 
repair of mismatches. These experiments are the first to demonstrate differential rates of 
repair at a hotspot of mutation and differential rates of repair for mismatches depending 
on local sequence context. Differences in binding by hM utSa were then observed in 
vitro both by gel-shift and UV cross-linking methods. These differences in binding 
generally correlate with mismatch repair efficiency in vivo. Importantly, these 
experiments were performed using two mismatch proficient cell lines, and thus the lack 
of mismatch repair and mismatch repair protein binding observed may have ramifications 
for initiation of tumorigenisis in individuals who are not hereditarily predisposed to 
cancer.
The general mechanisms of long-patch mismatch repair are currently of great 
interest as it has been shown that these genes are often mutated in spontaneous tumors
I l l
and that individuals mutant in the mismatch repair genes are hereditarily predisposed to 
cancer. The mismatch repair protein-protein and protein-DNA interactions were 
examined in these studies. Two novel mismatch repair protein complexes were observed, 
one consisting of at least hMSH2, hMSH6, hMLHl and hPMS2 and the other consisting 
of at least hMSH2, hMSH6, hMLHl and hPM Sl. Identification of these protein 
complexes, their interactions with heteroduplex DNA, and the effect of ATP was then 
examined. Additionally, a novel complex that forms after addition of ATP and involves 
hMLH 1 was detected. These results add to our rapidly expanding knowledge of the 
mismatch repair system and hopefully are an essential step in future understanding of the 
mechanisms involved in tumorigenesis in humans.
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